USRE31006E
(en)
*
|
1968-09-24 |
1982-08-03 |
Akzona Incorporated |
Process for the demonstration and determination of reaction components having specific binding affinity for each other
|
NL171930C
(en)
*
|
1972-05-11 |
1983-06-01 |
Akzo Nv |
METHOD FOR DETERMINING AND DETERMINING BITES AND TEST PACKAGING.
|
US3790447A
(en)
*
|
1972-07-05 |
1974-02-05 |
Abbott Lab |
Streptococci diagnostic method
|
US4239746A
(en)
*
|
1973-06-30 |
1980-12-16 |
Dezso Istvan Bartos |
Complement fixation test employing reactants in a disposable package
|
DE2333434C3
(en)
*
|
1973-06-30 |
1978-04-06 |
Istvan D. Dr. 5024 Pulheim Bartos |
Process for carrying out serological tests according to the principle of the complement fixation reaction and ready-to-use rapid test pack for this
|
US3935074A
(en)
*
|
1973-12-17 |
1976-01-27 |
Syva Company |
Antibody steric hindrance immunoassay with two antibodies
|
GB1508132A
(en)
*
|
1974-05-20 |
1978-04-19 |
Technicon Instr |
Analysis of biological fluids
|
US4040907A
(en)
*
|
1974-06-20 |
1977-08-09 |
Syva Company |
Iodothyronine enzyme conjugates
|
US4001087A
(en)
*
|
1974-10-10 |
1977-01-04 |
The United States Of America |
Affinity labelling enzymes with esters of aromatic sulfonic acids
|
FR2288312A1
(en)
*
|
1974-10-14 |
1976-05-14 |
Pasteur Institut |
PROGESTERONE IMMUNOENZYMATIC ASSAY PROCESS
|
US4002532A
(en)
*
|
1974-10-21 |
1977-01-11 |
Weltman Joel K |
Enzyme conjugates
|
SE388694B
(en)
*
|
1975-01-27 |
1976-10-11 |
Kabi Ab |
WAY TO PROVIDE AN ANTIGEN EXV IN SAMPLES OF BODY WHEATS, USING POROST BERAR MATERIAL BONDED OR ADSORBING ANTIBODIES
|
NL7501215A
(en)
*
|
1975-02-01 |
1976-08-03 |
Akzo Nv |
METHOD FOR DETERMINING AND DETERMINING AN ANTIGEN OR ANTIBODY.
|
US4629688A
(en)
*
|
1975-04-28 |
1986-12-16 |
Miles Laboratories, Inc. |
Homogeneous specific binding assay method
|
US4230797A
(en)
*
|
1975-04-28 |
1980-10-28 |
Miles Laboratories, Inc. |
Heterogenous specific binding assay employing a coenzyme as label
|
USRE32696E
(en)
*
|
1975-09-04 |
1988-06-14 |
Akzona Incorporated |
Enzymatic immunological method for determination of antigens and antibodies
|
US4474878A
(en)
*
|
1975-09-29 |
1984-10-02 |
Cordis Laboratories, Inc. |
Sandwich EIA for antigen associated with hepatitis
|
US4642285A
(en)
*
|
1975-09-29 |
1987-02-10 |
Diamedix Corporation |
Sandwich EIA for antigen
|
SE7610683L
(en)
*
|
1975-09-29 |
1977-06-10 |
Cordis Corp |
METHOD OF DETERMINING THE NERVARON OF AN ANTIGEN ASSOCIATE WITH HEPATITIS
|
JPS5272284A
(en)
*
|
1975-12-12 |
1977-06-16 |
Dainippon Pharmaceutical Co |
Enzymeeimmunoassay reagent
|
US4045384A
(en)
*
|
1976-07-23 |
1977-08-30 |
The Dow Chemical Company |
Method for forming an amide bond between a latex and protein
|
GB1549069A
(en)
*
|
1976-12-10 |
1979-08-01 |
Erba Farmitalia |
Enzyme linked immunoassay
|
US4407943A
(en)
*
|
1976-12-16 |
1983-10-04 |
Millipore Corporation |
Immobilized antibody or antigen for immunoassay
|
US4200690A
(en)
*
|
1976-12-16 |
1980-04-29 |
Millipore Corporation |
Immunoassay with membrane immobilized antibody
|
JPS5399319A
(en)
*
|
1977-02-09 |
1978-08-30 |
Hidematsu Hirai |
Novel qualitative and quantitative detecting method and detecting body for antgenic substance
|
IT1114861B
(en)
*
|
1977-05-12 |
1986-01-27 |
Sclavo Inst Sieroterapeut |
METHOD FOR DETERMINING THE CONTENT OF CONSTITUENTS OF BIOLOGICAL FLUIDS AND MEANS SUITABLE FOR THE PURPOSE
|
US4233402A
(en)
*
|
1978-04-05 |
1980-11-11 |
Syva Company |
Reagents and method employing channeling
|
AU531777B2
(en)
*
|
1978-04-05 |
1983-09-08 |
Syva Co. |
Label/solid conjugate immunoassay system
|
US4318980A
(en)
*
|
1978-04-10 |
1982-03-09 |
Miles Laboratories, Inc. |
Heterogenous specific binding assay employing a cycling reactant as label
|
US4492751A
(en)
*
|
1978-04-10 |
1985-01-08 |
Miles Laboratories, Inc. |
Heterogenous specific binding assay employing an enzyme substrate as label
|
US5605800A
(en)
*
|
1978-04-13 |
1997-02-25 |
Institut Pasteur |
Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method
|
FR2422956A1
(en)
*
|
1978-04-13 |
1979-11-09 |
Pasteur Institut |
METHOD OF DETECTION AND CHARACTERIZATION OF A NUCLEIC ACID OR OF A SEQUENCE OF THE SAME, AND ENZYMATIC REAGENT FOR THE IMPLEMENTATION OF THIS PROCESS
|
JPS5510590A
(en)
*
|
1978-05-04 |
1980-01-25 |
Wellcome Found |
Enzyme immunity quantity analysis
|
JPS5539702A
(en)
*
|
1978-08-30 |
1980-03-19 |
Takeda Chem Ind Ltd |
Method of measuring enzyme immunity of pancreas glucagon
|
FR2440555A1
(en)
*
|
1978-10-31 |
1980-05-30 |
Maes Roland |
IMPROVEMENTS IN METHODS OF DETERMINING SUBSTANCES SHOWING SPECIFIC BINDING AFFINITIES BETWEEN THEM, BY TESTS INVOLVING A SOLID PHASE
|
US4260678A
(en)
*
|
1979-02-23 |
1981-04-07 |
Corning Glass Works |
Determining creatine kinase isoenzmes via immobilized antibody-isoenzyme complexes
|
JPS55152459A
(en)
*
|
1979-05-18 |
1980-11-27 |
Yamasa Shoyu Co Ltd |
Method and reagent for measuring quantity of cyclic nucleotide
|
US4289748A
(en)
*
|
1979-05-31 |
1981-09-15 |
United States Of America |
Ultrasensitive enzymatic radioimmunoassay method
|
DE2930706A1
(en)
*
|
1979-07-28 |
1981-02-05 |
Medac Klinische Spezialpraep |
METHOD FOR DETECTING POTENTIAL-SPECIFIC ANTIBODY
|
US4299916A
(en)
*
|
1979-12-26 |
1981-11-10 |
Syva Company |
Preferential signal production on a surface in immunoassays
|
US4394391A
(en)
*
|
1980-02-19 |
1983-07-19 |
Thorell Jan Ivan |
Radioimmunoassay reagents
|
US4322495A
(en)
*
|
1980-03-11 |
1982-03-30 |
Minnesota Mining And Manufacturing Co. |
Immunoassay
|
SE8003732L
(en)
*
|
1980-05-19 |
1981-11-20 |
Pharmacia Diagnostics Ab |
SET FOR DETERMINATION METHODS INVOLVING BIOSPECIFIC AFFINITY REACTIONS
|
EP0040728A1
(en)
*
|
1980-05-19 |
1981-12-02 |
Pharmacia Diagnostics Ab |
An improvement in and relating to assaying methods involving biospecific affinity reactions
|
JPS5714748A
(en)
*
|
1980-07-01 |
1982-01-26 |
Dainippon Pharmaceut Co Ltd |
Kit for quantitative determination of valproic acid and its method for quantitative determination
|
US4323647A
(en)
*
|
1980-10-15 |
1982-04-06 |
University Of Miami |
Steric hindrance enzyme immunoassay
|
DE3048884A1
(en)
*
|
1980-12-23 |
1982-07-15 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
METHOD FOR ENZYME IMMUNE DETERMINATION IN HETEROGENEOUS PHASE
|
US4604365A
(en)
*
|
1981-06-02 |
1986-08-05 |
Electro-Nucleonics, Inc. |
Immunoprecipitation assay
|
WO1982004323A1
(en)
*
|
1981-06-02 |
1982-12-09 |
O Neill Sean |
Immunoprecipitation assay
|
US4506009A
(en)
*
|
1982-03-30 |
1985-03-19 |
University Of California |
Heterogeneous immunoassay method
|
US4535057A
(en)
*
|
1982-07-26 |
1985-08-13 |
Amf Incorporated |
Immunoassay employing monoclonal herpes simplex antibody and biotin-avidin detection system
|
US4515890A
(en)
*
|
1982-11-08 |
1985-05-07 |
Abbott Laboratories |
Immunoassay of terminal deoxynucleotidyl transferase
|
US4650751A
(en)
*
|
1983-04-29 |
1987-03-17 |
Technicon Instruments Corporation |
Protected binding assay avoiding non-specific protein interference
|
US4778752A
(en)
*
|
1983-10-11 |
1988-10-18 |
Scripps Clinic And Research Foundation |
Receptors specific for hapten-modified self proteins
|
US4937199A
(en)
*
|
1985-03-18 |
1990-06-26 |
The Royal Free Hospital School Of Medicine |
Detection of viruses and antibodies
|
JPS62148857A
(en)
*
|
1985-12-24 |
1987-07-02 |
Toyo Soda Mfg Co Ltd |
Production of material for immunological measurement
|
EP0247730A3
(en)
*
|
1986-04-28 |
1989-04-12 |
Antibody Technology Limited |
Antibodies, their preparation and use and products containing them
|
DE3636724A1
(en)
*
|
1986-10-29 |
1988-06-23 |
Joern Dr Med Kekow |
Enzyme immunoassay (ELISA) for determining insulin in an microtitre plate system
|
US6528292B1
(en)
*
|
1987-05-29 |
2003-03-04 |
Aventis Pharmaceuticals Holdings Inc. |
Derivatized polystyrene and other polymer supports for spectroscopic studies
|
US5256372A
(en)
*
|
1987-11-06 |
1993-10-26 |
Idexx Corporation |
Dipstick test device including a removable filter assembly
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
US5965379A
(en)
*
|
1991-07-19 |
1999-10-12 |
Cytimmune Sciences Inc. |
Method for measuring endogenous cytokines
|
ATE184703T1
(en)
*
|
1991-07-19 |
1999-10-15 |
Cytimmune Sciences Inc |
METHOD AND TEST SET FOR MEASURING ENDOGENE CYTOKINES
|
US5464749A
(en)
|
1991-07-22 |
1995-11-07 |
Bayer Corporation |
Immunoassay of free substances in biological fluids
|
US5874423A
(en)
*
|
1992-09-10 |
1999-02-23 |
Yissum Research Development Co. Of The Hebrew University Of Jerusalem |
Digitalis-like compounds
|
US5637467A
(en)
*
|
1992-10-13 |
1997-06-10 |
Behringwerke Ag |
Heterogeneous assay using a pendulous drop
|
WO1995034640A1
(en)
*
|
1994-06-13 |
1995-12-21 |
Henry Ford Health System |
A novel neuronal-neonatal gene: neuronatin
|
US5843673A
(en)
*
|
1994-10-25 |
1998-12-01 |
Curators Of The University Of Missouri |
Method of screening for endometriosis
|
US6531277B2
(en)
|
1994-10-25 |
2003-03-11 |
The Curators Of The University Of Missouri |
Endometriosis-specific secretory protein
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
US5607565A
(en)
*
|
1995-03-27 |
1997-03-04 |
Coulter Corporation |
Apparatus for measuring analytes in a fluid sample
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
US5858661A
(en)
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
US6096508A
(en)
*
|
1995-08-16 |
2000-08-01 |
Kirkegaard & Perry Laboratoies, Inc. |
Method of reducing background in biotin-based assays
|
US5840322A
(en)
*
|
1996-12-19 |
1998-11-24 |
Ramot-University Authority For Applied Research & Industrial Devel. Ltd. |
Anti-oral-microbial adhesion fraction derived from vaccinium
|
AU9110798A
(en)
*
|
1997-08-21 |
1999-03-08 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
US7973156B2
(en)
|
1997-08-21 |
2011-07-05 |
Quark Pharmaceuticals Inc. |
Hypoxia-regulated genes
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
CA2307345A1
(en)
|
1997-10-17 |
1999-04-29 |
University Of South Florida |
Method to diagnose and monitor cellular immune deficiencies
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
AU770896C
(en)
|
1998-09-29 |
2006-09-07 |
Gamida Cell Ltd. |
Methods of controlling proliferation and differentiation of stem and progenitor cells
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
US7605149B1
(en)
|
1998-07-13 |
2009-10-20 |
University Of South Florida |
Modulation of the phospholipase A2 pathway as a therapeutic
|
US6187563B1
(en)
|
1998-08-07 |
2001-02-13 |
Yale University |
βIV-spectrin-polypeptides and nucleic acids encoding same
|
ES2338405T3
(en)
|
1999-02-04 |
2010-05-07 |
Pluristem Ltd. |
METHOD AND APPARATUS FOR MAINTENANCE AND EXPASION OF HEMOPOYTIC MOTHER CELLS AND / OR PROGENITOR CELLS.
|
US6440682B1
(en)
*
|
1999-05-28 |
2002-08-27 |
Detroit R&D Inc. |
Detection of hypertension using immunoreactive metabolic products
|
US6787318B1
(en)
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US7534605B2
(en)
*
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
CA2377541A1
(en)
*
|
1999-06-25 |
2001-01-04 |
Eduardo N. Mitrani |
Method of inducing angiogenesis by micro-organs
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US7811981B2
(en)
*
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US7101839B1
(en)
|
1999-08-30 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
CA2392060C
(en)
*
|
1999-11-19 |
2007-07-10 |
Yissum Research Development Company Of The Hebrew University In Jerusalem |
Aspergillus niger beta-glucosidase gene, protein and uses thereof
|
US6544506B2
(en)
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
US7385106B2
(en)
*
|
2000-01-24 |
2008-06-10 |
Ramot At Tel Aviv University Ltd. |
Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
|
US20040191260A1
(en)
*
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
IL151860A0
(en)
|
2000-03-27 |
2003-04-10 |
Technion Res & Dev Foundation |
Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
HUP0300810A2
(en)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Artifical vascular grafts, and methods of producing and using same
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
DK2359854T3
(en)
|
2000-08-08 |
2013-11-04 |
Technion Res & Dev Foundation |
Pharmaceutical compositions and methods suitable for modulating angiogenesis
|
US20030114410A1
(en)
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
EP1683874A3
(en)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
IL155097A0
(en)
*
|
2000-09-28 |
2003-10-31 |
Nanocyte Inc |
Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
|
US7632522B2
(en)
*
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
CA2429342C
(en)
|
2000-11-17 |
2013-03-19 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same
|
AU2002218461B2
(en)
|
2000-11-24 |
2006-09-07 |
Vascular Biogenics Ltd |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
JP2004524010A
(en)
|
2000-11-30 |
2004-08-12 |
モルキューラー スキンケア リミテッド |
Diagnosis and treatment of disease
|
EP1337152A4
(en)
*
|
2000-11-30 |
2004-08-11 |
Yeda Res & Dev |
Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
|
AU2002236608A1
(en)
*
|
2000-12-14 |
2002-06-24 |
Nyxis Neurotherapies, Inc. |
High throughput assay to detect inhibitors of the map kinase pathway
|
US7087395B1
(en)
|
2001-01-16 |
2006-08-08 |
Quest Diagnostics Investments Incorporated |
Vitamin D assay
|
CA2440317A1
(en)
*
|
2001-01-17 |
2002-07-25 |
Ramot At Tel Aviv University Ltd. |
Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same
|
US20050202098A1
(en)
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
WO2002060376A2
(en)
*
|
2001-01-31 |
2002-08-08 |
Tolaren |
Induction of tolerance by apoptotic and/or necrotic cells
|
US20030003454A1
(en)
|
2001-03-23 |
2003-01-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
WO2003008534A2
(en)
*
|
2001-07-19 |
2003-01-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof
|
US7442781B2
(en)
|
2001-08-16 |
2008-10-28 |
Urifer Ltd. |
Diagnosis, prevention and treatment of cancer
|
US7138144B2
(en)
*
|
2001-09-07 |
2006-11-21 |
Nadir Askenasy |
Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
US20060068405A1
(en)
*
|
2004-01-27 |
2006-03-30 |
Alex Diber |
Methods and systems for annotating biomolecular sequences
|
EP2277887A3
(en)
|
2001-10-19 |
2011-02-16 |
Vascular Biogenics Ltd. |
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
|
AUPR842501A0
(en)
*
|
2001-10-23 |
2001-11-15 |
Epipop Pty Ltd |
A method for identification and development of therapeutic agents
|
US8178128B2
(en)
*
|
2001-12-05 |
2012-05-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Nanoparticles containing polymeric nucleic acid homologs
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
IL152904A0
(en)
*
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
WO2003062404A1
(en)
|
2002-01-25 |
2003-07-31 |
Gamida-Cell Ltd. |
Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US6992176B2
(en)
*
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
JP2005533486A
(en)
*
|
2002-02-20 |
2005-11-10 |
ダイアックス、コープ |
MHC-peptide complex binding ligand
|
US20050220774A1
(en)
*
|
2002-03-18 |
2005-10-06 |
Tony Peled |
Methods of inducing differentiation in ex vivo expanded stem cells
|
EP1519755B1
(en)
*
|
2002-03-26 |
2008-05-07 |
Nanocyte Inc. |
Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
AU2003242967A1
(en)
*
|
2002-07-12 |
2004-02-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method and device for inducing biological processes by micro-organs
|
EP1524989B1
(en)
|
2002-08-01 |
2013-11-06 |
Yeda Research And Development Co., Ltd. |
Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
AU2003284968A1
(en)
*
|
2002-10-25 |
2004-05-13 |
University Of South Florida |
Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
|
EP2295980A1
(en)
|
2002-10-30 |
2011-03-16 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Molecules and methods using same for measuring non-transferrin bound iron
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
WO2004050826A2
(en)
*
|
2002-11-29 |
2004-06-17 |
Technion Research & Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
ATE486637T1
(en)
|
2002-12-12 |
2010-11-15 |
R B T Rakuto Bio Technologies |
USE OF LIGNIN PEROXIDASE FOR SKIN AND HAIR LIGHTENING
|
ES2571355T3
(en)
|
2002-12-16 |
2016-05-24 |
Technion Res & Dev Foundation |
Culture system without feeder cells or xenocontaminants for human embryonic stem cells
|
WO2004060135A2
(en)
|
2003-01-02 |
2004-07-22 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients
|
EP2058275A1
(en)
|
2003-01-07 |
2009-05-13 |
Ramot at Tel-Aviv University Ltd. |
Peptide nanostructures encapsulating a foreign material and method of manufacturing same
|
EP2319857A3
(en)
|
2003-03-04 |
2012-06-27 |
Yeda Research And Development Co., Ltd. |
Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same
|
EP1601759A4
(en)
*
|
2003-03-07 |
2007-02-14 |
Gamida Cell Ltd |
Expansion of renewable stem cell populations using modulators of pi 3-kinase
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
DK2330132T3
(en)
|
2003-04-04 |
2013-11-04 |
Yeda Res & Dev |
Antibodies to MMP2 or MMP9 and pharmaceutical compositions thereof to inhibit their metalloprotein activity
|
AU2004227204B2
(en)
|
2003-04-08 |
2010-06-03 |
Yeda Research And Development Co. Ltd |
Stem cells having increased sensitivity to SDF-1 and methods of generating and using same
|
FR2853551B1
(en)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
STABILIZING FORMULATION FOR IMMUNOGLOBULIN G COMPOSITIONS IN LIQUID FORM AND LYOPHILIZED FORM
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
MXPA05012565A
(en)
|
2003-05-22 |
2006-05-25 |
Evogene Ltd |
Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby.
|
AU2005234725B2
(en)
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
US7554007B2
(en)
*
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
US20050020499A1
(en)
*
|
2003-05-27 |
2005-01-27 |
Bar Ilan University |
Methods of attenuating ***e seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
|
WO2004111183A2
(en)
*
|
2003-06-19 |
2004-12-23 |
Evogene Ltd. |
Plant trichome-specific promoter and leucoplast signal sequence
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
EP1638517A4
(en)
|
2003-06-30 |
2010-01-06 |
Univ Tel Aviv Future Tech Dev |
Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
|
US20050271643A1
(en)
*
|
2003-08-14 |
2005-12-08 |
Iryna Sorokulova |
Bacterial strains, compositions including same and probiotic use thereof
|
US7625707B2
(en)
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
SI1678209T1
(en)
|
2003-10-07 |
2011-07-29 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
US20060257429A1
(en)
*
|
2003-10-23 |
2006-11-16 |
Dreier Kimberly J |
Vaccine for periodontal disease
|
JP5039383B2
(en)
|
2003-11-30 |
2012-10-03 |
イエダ リサーチ アンド ディベロップメント カンパニー リミテッド |
Methods and agents for immune modulation and methods of identifying immune modulators
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
EP2289567A3
(en)
|
2003-12-22 |
2011-06-22 |
Regentis Biomaterials Ltd. |
Matrix comprising naturally-occurring crosslinked protein backbone
|
US8007847B2
(en)
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
JP2007526337A
(en)
|
2004-03-02 |
2007-09-13 |
アクセルロン ファーマ インコーポレーテッド |
ALK7 and myostatin inhibitors and uses thereof
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
EP1766058A4
(en)
*
|
2004-06-14 |
2008-05-21 |
Evogene Ltd |
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
|
US8680062B2
(en)
*
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2006006172A2
(en)
*
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
WO2006030442A2
(en)
|
2004-09-16 |
2006-03-23 |
Gamida-Cell Ltd. |
Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
|
US8000900B2
(en)
|
2004-09-21 |
2011-08-16 |
Microsoft Corporation |
Association-based predictions of pathogen characteristics
|
US20060095241A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
US8039240B2
(en)
*
|
2004-09-29 |
2011-10-18 |
Yissum Reseach Development Company Of The Hebrew University Of Jerusalem |
Recombinant human T2 RNase and uses thereof
|
EP1809751B1
(en)
|
2004-09-29 |
2010-09-01 |
CollPlant Ltd. |
Collagen producing plants and methods of generating and using same
|
WO2006040765A1
(en)
*
|
2004-10-12 |
2006-04-20 |
Closed Loop Therapies Ltd. |
Methods and implantable devices for treating supraventricular arrhythmias
|
US8478535B2
(en)
|
2004-10-29 |
2013-07-02 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
US20060134680A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Alexander Kotlyar |
Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
|
JP2008529325A
(en)
*
|
2005-01-16 |
2008-07-31 |
ズランゴー リミテッド |
Communication network system and method for using the same
|
WO2006075334A2
(en)
|
2005-01-16 |
2006-07-20 |
Zlango Ltd. |
Iconic communication
|
US8019818B2
(en)
*
|
2005-01-18 |
2011-09-13 |
Zlango Ltd. |
Communications network system and methods for using same
|
ES2562406T3
(en)
|
2005-01-31 |
2016-03-04 |
Realbio Technologies Ltd. |
Multi-stage reaction lateral flow capillary device
|
AU2006215300C9
(en)
|
2005-02-17 |
2010-05-06 |
Hadasit Medical Research Services And Development Ltd. |
Bisphosphonates for treating endometriosis
|
WO2006090388A2
(en)
|
2005-02-25 |
2006-08-31 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center |
Fruit cell culture extract for treating inflammation
|
US7695927B2
(en)
*
|
2005-03-18 |
2010-04-13 |
Detroit R & D |
Detection of hypertension using glucuronidated metabolic products
|
WO2006109312A2
(en)
*
|
2005-04-15 |
2006-10-19 |
Vascular Biogenics Ltd. |
Compositions containing beta 2-glycoprotein i-derived peptides for the prevention and/or treatment of vascular disease
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
ES2609919T3
(en)
|
2005-04-28 |
2017-04-25 |
Ventana Medical Systems, Inc. |
Enzymes conjugated to antibodies using a heterobifunctional PEG linker
|
EP1893241A2
(en)
*
|
2005-04-28 |
2008-03-05 |
Ventana Medical Systems, Inc. |
Fluorescent nanoparticles conjugated to antibodies via a peg linker
|
WO2006126208A2
(en)
|
2005-05-26 |
2006-11-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
|
ES2524996T3
(en)
|
2005-06-16 |
2014-12-16 |
Ramot At Tel Aviv University Ltd. |
Isolated cells and populations that comprise them for the treatment of CNS diseases
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
CA2613619A1
(en)
|
2005-07-07 |
2007-01-18 |
Fulcrum Sp Ltd. |
Sp1 polypeptides, modified sp1 polypeptides and uses thereof
|
WO2007007317A1
(en)
*
|
2005-07-07 |
2007-01-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acid agents for downregulating h19, and methods of using same
|
EP1904638A2
(en)
|
2005-07-18 |
2008-04-02 |
Metabogal Ltd. |
Mucosal or enteral administration of biologically active macromolecules
|
CA2616766A1
(en)
|
2005-07-26 |
2007-02-01 |
University Of Medicine And Dentistry Of New Jersey |
Antibody profiles characteristic of tuberculosis state
|
US8642330B2
(en)
*
|
2005-08-08 |
2014-02-04 |
Onconon, Llc |
Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
|
US8916147B2
(en)
|
2005-08-24 |
2014-12-23 |
Yeda Research and Devolpment Co. Ltd. |
Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
|
EP3354723B1
(en)
|
2005-08-29 |
2023-12-13 |
Technion Research & Development Foundation Ltd. |
Media for culturing stem cells
|
DE602006014009D1
(en)
|
2005-09-22 |
2010-06-10 |
Yissum Res Dev Co |
NUCLEIC ACID CONSTRUCTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
CA2626592C
(en)
|
2005-10-24 |
2018-07-17 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and fertilizer use efficiency of a plant
|
EP1950166B1
(en)
*
|
2005-11-18 |
2014-05-07 |
Mitsubishi Denki Kabushiki Kaisha |
Device for lighting elevator car
|
CN101535244B
(en)
*
|
2005-11-23 |
2014-07-23 |
文塔納医疗***公司 |
Molecular conjugate
|
CA2632288A1
(en)
|
2005-11-29 |
2007-06-07 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
US20070134739A1
(en)
*
|
2005-12-12 |
2007-06-14 |
Gyros Patent Ab |
Microfluidic assays and microfluidic devices
|
WO2007069940A1
(en)
|
2005-12-12 |
2007-06-21 |
Gyros Patent Ab |
Microfluidic assays and microfluidic devices
|
US8775526B2
(en)
|
2006-01-16 |
2014-07-08 |
Zlango Ltd. |
Iconic communication
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US7553941B2
(en)
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting polypeptides and methods of producing same
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
CA2641079A1
(en)
|
2006-02-06 |
2007-08-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods and kit for diagnosing t1dm
|
WO2007102146A2
(en)
|
2006-03-06 |
2007-09-13 |
Zetiq Technologies Ltd. |
Methods and compositions for identifying a cell phenotype
|
ES2572214T3
(en)
|
2006-03-23 |
2016-05-30 |
Pluristem Ltd |
Methods for cell expansion and uses of cells and conditioned media produced in this way for therapy
|
WO2007110869A2
(en)
|
2006-03-28 |
2007-10-04 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to warfarin resistance
|
KR20090029184A
(en)
*
|
2006-04-07 |
2009-03-20 |
더 가브먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
Antibody compositions and methods for treatment of neoplastic disease
|
CA2652538C
(en)
*
|
2006-05-19 |
2016-06-28 |
Teva Pharmaceutical Industries, Ltd. |
Fusion proteins, uses thereof and processes for producing same
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
WO2008010228A2
(en)
|
2006-07-20 |
2008-01-24 |
Yeda Research And Development Co. Ltd. |
Photosyntheticorganisms and compositions and methods of generating same
|
US8809052B2
(en)
|
2006-08-28 |
2014-08-19 |
Yeda Research And Development Co. Ltd. |
Methods of generating mature oligodendrocytes
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
CA2664972C
(en)
|
2006-10-05 |
2016-07-26 |
Technion Research & Development Foundation Ltd. |
Microtubes and methods of producing same
|
CA2672756C
(en)
*
|
2006-12-20 |
2018-11-20 |
Evogene Ltd. |
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
|
EP2111450A2
(en)
*
|
2007-01-16 |
2009-10-28 |
Yissum Research Development Company of the Hebrew University of Jerusalem |
Nucleic acid constructs and methods for specific silencing of h19
|
US20100196403A1
(en)
*
|
2007-01-29 |
2010-08-05 |
Jacob Hochman |
Antibody conjugates for circumventing multi-drug resistance
|
WO2008093341A2
(en)
|
2007-01-31 |
2008-08-07 |
Technion Research & Development Foundation Ltd. |
Electrospun scaffolds and methods of generating and using same
|
AU2008211549B2
(en)
|
2007-02-01 |
2012-12-06 |
Abraham Katzir |
Albumin fibers and fabrics and methods of generating and using same
|
EP2839839B1
(en)
|
2007-02-28 |
2018-01-17 |
Yeda Research And Development Company Limited |
Nuclear targeting sequences
|
WO2008120202A2
(en)
|
2007-03-29 |
2008-10-09 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
KR20100015774A
(en)
|
2007-04-02 |
2010-02-12 |
라모트 앳 텔-아비브 유니버시티 리미티드 |
Methods of detecting cancer cells and use of same for diagnosing and monitoring treatment of the disease
|
MX341624B
(en)
|
2007-04-09 |
2016-08-26 |
Evogene Ltd |
Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants.
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
PT2144633E
(en)
*
|
2007-04-23 |
2014-10-27 |
Deliversir Ltd |
A system for delivering therapeutic agents into living cells and cells nuclei
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
EP3032259B1
(en)
|
2007-05-01 |
2020-04-15 |
Tel Hashomer Medical Research Infrastructure and Services Ltd. |
Methods for detecting trophoblast cells in maternal blood based on cytokeratin-7
|
DK2150276T3
(en)
|
2007-05-03 |
2014-08-18 |
Agency Science Tech & Res |
ANTIBODIES BINDING TO AN INTRACELLULAR PRL-1 OR PRL-3 POLYPEPTIDE
|
ES2660667T3
(en)
|
2007-05-07 |
2018-03-23 |
Protalix Ltd. |
Large-scale disposable bioreactor
|
US20100197767A1
(en)
|
2007-07-11 |
2010-08-05 |
Lior Nissim |
Nucleic acid construct systems capable of daignosing or treating a cell state
|
CA2696833A1
(en)
|
2007-07-15 |
2009-01-22 |
Yitzchak Hillman |
Disease treatment via antimicrobial peptides or their inhibitors
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
ES2547305T3
(en)
|
2007-07-24 |
2015-10-05 |
Evogene Ltd. |
Polynucleotides, polypeptides encoded by them, and methods of using them to increase tolerance to abiotic stress and / or biomass and / or yield in plants that express them
|
EP2537529B1
(en)
|
2007-08-02 |
2018-10-17 |
Gilead Biologics, Inc. |
Loxl2 inhibitory antibodies and uses thereof
|
RU2474433C2
(en)
|
2007-08-15 |
2013-02-10 |
ЙЕДА РЕСЕАРЧ ЭНД ДЕВЕЛОПМЕНТ КО. ЛТД, эт ве Вайзманн Институте оф Сайнсе |
Mmp-9 regulators and use thereof
|
CN101855549A
(en)
|
2007-09-12 |
2010-10-06 |
耶达研究及发展有限公司 |
Methods of treating tumors in immune-privileged sites
|
KR20140107677A
(en)
|
2007-09-19 |
2014-09-04 |
플루리스템 리미티드 |
Adherent cells from adipose or placenta tissues and use thereof in therapy
|
ES2620487T3
(en)
|
2007-10-19 |
2017-06-28 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions comprising semaforins for use in the treatment of cancer
|
EP2220112B1
(en)
|
2007-11-26 |
2015-08-26 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Compositions comprising fibrous polypeptides and polysaccharides
|
MX357387B
(en)
|
2007-12-27 |
2018-07-06 |
Evogene Ltd |
Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants.
|
US20110052501A1
(en)
*
|
2008-01-31 |
2011-03-03 |
Liat Dassa |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
WO2009104174A2
(en)
|
2008-02-21 |
2009-08-27 |
Technion Research & Development Foundation Ltd . |
A method of attaching a cell-of-interest to a microtube
|
EP2297200A1
(en)
*
|
2008-04-09 |
2011-03-23 |
Technion Research & Development Foundation Ltd. |
Anti influenza antibodies and uses thereof
|
WO2009125394A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Technion Research & Development Foundation Ltd. |
Anti human immunodeficiency antibodies and uses thereof
|
WO2009125381A1
(en)
*
|
2008-04-10 |
2009-10-15 |
Objet Geometries Ltd. |
System and method for three dimensional model printing
|
US9095569B2
(en)
|
2008-04-18 |
2015-08-04 |
Collplant Ltd. |
Methods of generating and using procollagen
|
US8791324B2
(en)
|
2008-04-21 |
2014-07-29 |
Danziger Innovations Ltd. |
Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
|
EP2116618A1
(en)
|
2008-05-09 |
2009-11-11 |
Agency for Science, Technology And Research |
Diagnosis and treatment of Kawasaki disease
|
MX2010012697A
(en)
|
2008-05-22 |
2011-03-15 |
Evogene Ltd |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant utility.
|
RU2515156C2
(en)
|
2008-05-27 |
2014-05-10 |
Плуристем Лтд. |
Methods of treating inflammatory diseases of colon
|
DK2620493T3
(en)
|
2008-05-28 |
2019-07-01 |
Univ Ramot |
Mesenchymal stem cells for the treatment of CNS diseases
|
US9952211B2
(en)
|
2008-06-29 |
2018-04-24 |
Realbio Technologies Ltd. |
Liquid-transfer device particularly useful as a capturing device in a biological assay process
|
EP2331107A4
(en)
|
2008-08-08 |
2011-08-24 |
Agency Science Tech & Res |
Vhz for diagnosis and treatment of cancers
|
AU2009279458B2
(en)
|
2008-08-08 |
2015-07-02 |
Code Biotherapeutics, Inc. |
Long-acting DNA dendrimers and methods thereof
|
MX2011001741A
(en)
|
2008-08-18 |
2011-03-29 |
Evogene Ltd |
Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants.
|
CN102282249A
(en)
|
2008-09-02 |
2011-12-14 |
普拉里斯坦有限公司 |
Adherent cells from placenta tissue and use thereof in therapy
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
EP2326340A4
(en)
|
2008-09-11 |
2013-01-23 |
Univ Ben Gurion |
Compositions and methods for treating s. pneumoniae infection
|
CN102186970A
(en)
|
2008-09-12 |
2011-09-14 |
克里奥普拉斯低温生物有限公司 |
Ischemic tissue cell therapy
|
CN104892728A
(en)
|
2008-09-24 |
2015-09-09 |
特尔哈肖梅尔医学研究基础设施和服务有限公司 |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
EP2342356A4
(en)
|
2008-09-29 |
2012-11-21 |
Univ Ben Gurion |
Amyloid beta-peptides and methods of use thereof
|
BRPI0914522B1
(en)
|
2008-10-30 |
2019-04-02 |
Evogene Ltd |
METHOD FOR INCREASING YIELD, BIOMASS, GROWTH RATE, STRENGTH, OIL OTEOR, AND / OR EFFICIENCY OF NITROGEN USE OF A PLANT
|
US20110229892A1
(en)
|
2008-11-17 |
2011-09-22 |
Yehuda G Assaraf |
Method for predicting a patient's responsiveness to anti-folate therapy
|
WO2010058396A1
(en)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A cd44vra antibody and diagnostic and therapeutic methods using same
|
WO2010061383A1
(en)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
A method of in-situ enrichment of foods with fructan
|
WO2010064231A1
(en)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods of analyzing a-i rna editing and nucleic acid constructs capable of same
|
US20120014927A1
(en)
|
2008-12-03 |
2012-01-19 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to cancer
|
US8734759B2
(en)
|
2008-12-05 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing and treating motor neuron diseases
|
WO2010071610A1
(en)
|
2008-12-19 |
2010-06-24 |
Agency For Science, Technology And Research (A*Star) |
Severe chikungunya biomarkers
|
CA2744827C
(en)
|
2008-12-29 |
2019-10-15 |
Evogene Ltd. |
Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance, biomass and/or yield in plants expressing same
|
CA2967412C
(en)
|
2008-12-29 |
2018-07-17 |
Tel Hashomer Medical Research, Infrastructure And Services Ltd. |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
WO2010076788A2
(en)
|
2008-12-29 |
2010-07-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting responsiveness to interferon treatment and treating hepatitis c infection
|
WO2010076794A1
(en)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Method of denitrifying brine and systems capable of same
|
US9107935B2
(en)
|
2009-01-06 |
2015-08-18 |
Gilead Biologics, Inc. |
Chemotherapeutic methods and compositions
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
WO2010086867A2
(en)
|
2009-02-02 |
2010-08-05 |
Ramot At Tel Aviv University Ltd. |
Peptides, pharmaceutical compositions comprising same and uses thereof
|
WO2010089707A1
(en)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Methods and kits for determining sensitivity or resistance of prostate cancer to radiation therapy
|
EP2465920B1
(en)
|
2009-02-26 |
2017-04-12 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Isolated populations of renal stem cells and methods of isolating and using same
|
AR075773A1
(en)
|
2009-03-02 |
2011-04-27 |
Evogene Ltd |
ISOLATED POLYETHYLES AND POLYUCLEOTIDES AND METHODS FOR USE IN INCREASING PLANT PERFORMANCE AND AGRICULTURAL CHARACTERISTICS
|
PL2406279T3
(en)
|
2009-03-09 |
2016-07-29 |
Univ Ramot |
Compositions for prevention and treatment of neurodegenerative diseases
|
WO2010103517A1
(en)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Soluble compositions for the treatment of cxcr3-ligand associated diseases
|
US20120020954A1
(en)
|
2009-03-30 |
2012-01-26 |
Anat Achiron |
Methods of predicting clinical course and treating multiple sclerosis
|
AU2010231514A1
(en)
|
2009-04-01 |
2011-11-03 |
Rappaport Family Institute For Research In The Medical Sciences |
A method of regulating proliferation and differentiation of keratinocytes
|
WO2010116375A1
(en)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Isolated peptides for regulating apoptosis
|
EP2990421B1
(en)
|
2009-04-30 |
2018-02-21 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Anti ceacam1 antibodies and methods of using same
|
WO2010134073A1
(en)
|
2009-05-19 |
2010-11-25 |
Zetiq Technologies Ltd. |
Kits for and methods of differential staining of cervical cancer cells and/or tissues
|
US20120083477A1
(en)
|
2009-05-27 |
2012-04-05 |
Yeda Research And Development Co. Ltd. |
Proteasome inhibitors and uses thereof
|
US20120078163A1
(en)
|
2009-05-27 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
WO2010137013A1
(en)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Crystallized photosystem i units from the pea plant and their use in solid state devices
|
EP2435078A1
(en)
|
2009-05-28 |
2012-04-04 |
Yeda Research and Development Co. Ltd. |
Methods of treating inflammation
|
MX363447B
(en)
|
2009-06-10 |
2019-03-22 |
Evogene Ltd |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance.
|
WO2010150259A1
(en)
|
2009-06-24 |
2010-12-29 |
Fund For Medical Research Development Of Infrastructure And Health Services -Rambam Medical Center |
Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(en)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions and methods for treating cancer
|
CA2768725A1
(en)
|
2009-07-21 |
2011-01-27 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
A method of diagnosing cancer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
WO2011021194A2
(en)
|
2009-08-17 |
2011-02-24 |
Technion Research & Development Foundation Ltd. |
Pericyte progenitor cells and methods of generating and using same
|
CA2771774A1
(en)
*
|
2009-08-21 |
2011-02-24 |
Gilead Biologics, Inc. |
In vitro screening assays
|
WO2011021171A1
(en)
|
2009-08-21 |
2011-02-24 |
Beeologics, Llc |
Preventing and curing beneficial insect diseases via plant transcribed molecules
|
AU2010284036B2
(en)
|
2009-08-21 |
2014-12-18 |
Gilead Biologics, Inc. |
Catalytic domains from lysyl oxidase and LOXL2
|
CN106619515A
(en)
|
2009-08-27 |
2017-05-10 |
工业研究与发展基金会有限公司 |
Liposomal compositions and uses of same
|
US9610331B2
(en)
|
2009-09-08 |
2017-04-04 |
Yeda Research And Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
WO2011030336A1
(en)
|
2009-09-08 |
2011-03-17 |
Ramot At Tel-Aviv University Ltd. |
Methods of diagnosing amyotrophic lateral sclerosis (als)
|
US20120171213A1
(en)
|
2009-09-10 |
2012-07-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating tumors
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
WO2011033506A2
(en)
|
2009-09-17 |
2011-03-24 |
Yeda Research And Development Co. Ltd. |
Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
CA2773935C
(en)
|
2009-09-17 |
2018-06-19 |
Ramot At Tel Aviv University Ltd. |
Peptides for the treatment of oxidative stress related disorders
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
CN102906263B
(en)
|
2009-10-14 |
2017-05-31 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
Composition for controlling watt mite in honeybee
|
WO2011046570A1
(en)
|
2009-10-16 |
2011-04-21 |
The University Of Medicine And Dentistry Of New Jersey |
Method for treating chronic nerve tissue injury using a cell therapy strategy
|
WO2011048600A1
(en)
|
2009-10-21 |
2011-04-28 |
Danziger Innovations Ltd. |
Generating genotypic variations in plant genomes by gamete infection
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
Knock-out mouse of the mo-1 gene, a gene associated with morbid obesity
|
EP2498806B1
(en)
|
2009-11-12 |
2014-12-31 |
Ramot at Tel-Aviv University Ltd. |
Compositions comprising pedf and uses of same in the treatment and prevention of ovary-related syndromes
|
EP4166652A1
(en)
|
2009-11-12 |
2023-04-19 |
Technion Research & Development Foundation Ltd. |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
WO2011058555A1
(en)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
A method of editing dna in a cell and constructs capable of same
|
US20120230974A1
(en)
|
2009-11-17 |
2012-09-13 |
Protalix Ltd |
Alkaline alpha galactosidase for the treatment of fabry disease
|
WO2011064773A1
(en)
|
2009-11-24 |
2011-06-03 |
Collplant Ltd. |
Method of generating collagen fibers
|
EP2806023B1
(en)
|
2009-11-30 |
2015-09-23 |
Pluristem Ltd. |
Adherent cells from placenta and use of same in disease treatment
|
WO2011067745A2
(en)
|
2009-12-06 |
2011-06-09 |
Rosetta Green Ltd. |
Compositions and methods for enhancing plants resistance to abiotic stress
|
EP2510098B1
(en)
|
2009-12-09 |
2015-02-11 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the cns
|
US9493785B2
(en)
|
2009-12-28 |
2016-11-15 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
EP3785712A1
(en)
|
2009-12-29 |
2021-03-03 |
Gamida-Cell Ltd. |
Methods for enhancing natural killer cell proliferation and activity
|
CA2786374C
(en)
|
2010-01-05 |
2019-01-22 |
Vascular Biogenics Ltd. |
Methods for use of a specific anti-angiogenic adenoviral agent
|
EP2523681A1
(en)
|
2010-01-12 |
2012-11-21 |
Vascular Biogenics Ltd. |
Methods of producing adenovirus vectors and viral preparations generated thereby
|
US8697078B2
(en)
|
2010-01-27 |
2014-04-15 |
Yeda Research And Development Co. Ltd. |
Antibodies that inhibit metalloproteins
|
CN103370080A
(en)
|
2010-02-04 |
2013-10-23 |
吉联亚生物科技有限公司 |
Antibodies that bind to lysyl oxidase-like 2 (LOXL2) and methods of use therefor
|
WO2011099006A2
(en)
|
2010-02-11 |
2011-08-18 |
Yeda Research And Development Co. Ltd. |
Enzymatic systems for carbon fixation and methods of generating same
|
WO2011104708A2
(en)
|
2010-02-24 |
2011-09-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Methods for inhibiting necrosis
|
WO2011107939A1
(en)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting efficacy of an anti-vegfa treatment for solid tumors
|
WO2011107994A1
(en)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Methods of measuring protein stability
|
US9267142B2
(en)
|
2010-03-08 |
2016-02-23 |
Yeda Research And Development Co. Ltd. |
Recombinant protein production in heterologous systems
|
MX2012010479A
(en)
|
2010-03-08 |
2012-10-09 |
Monsanto Technology Llc |
Polynucleotide molecules for gene regulation in plants.
|
WO2011111050A2
(en)
|
2010-03-11 |
2011-09-15 |
Jacob Edrei |
Methods of generating hydrogen
|
US9073990B2
(en)
|
2010-04-05 |
2015-07-07 |
Bar-Llan University |
Protease-activatable pore-forming polypeptides
|
US8927274B2
(en)
|
2010-04-12 |
2015-01-06 |
Technion Research & Development Foundation Limited |
Populations of pancreatic progenitor cells and methods of isolating and using same
|
WO2011128895A2
(en)
|
2010-04-12 |
2011-10-20 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransferase of a red microalga and uses thereof
|
CN103109185A
(en)
|
2010-04-18 |
2013-05-15 |
耶达研究及发展有限公司 |
Molecules and methods of using same for treating erbb/erbb ligands associated diseases
|
BR122021002340B1
(en)
|
2010-04-28 |
2022-04-05 |
Evogene Ltd |
Method of increasing a plant's biomass, growth rate and/or nitrogen use efficiency
|
US20130053277A1
(en)
|
2010-05-04 |
2013-02-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
WO2011138785A2
(en)
|
2010-05-05 |
2011-11-10 |
Rappaport Family Institute For Research In The Medical Sciences |
Use of ccl1 in therapy
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
EP2569417B1
(en)
|
2010-05-13 |
2018-04-18 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Isolated populations of adult renal cells and methods of isolating and using same
|
EP2390664B1
(en)
|
2010-05-25 |
2013-04-17 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Method for electrochemical detection of binding reactions
|
US8945943B2
(en)
|
2010-05-26 |
2015-02-03 |
The Board Of Trustees Of The University Of Illinois |
Personal glucose meters for detection and quantification of a broad range of analytes
|
EP2575859B1
(en)
|
2010-06-03 |
2018-09-19 |
Ramot at Tel Aviv University, Ltd. |
Methods of treating diabetes and compositions capable of same
|
US20130316351A1
(en)
|
2010-06-07 |
2013-11-28 |
Osnat Ashur-Fabian |
Methods and kits for diagnosing conditions related to hypoxia
|
WO2011158243A2
(en)
|
2010-06-16 |
2011-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of diagnosing and treating cancer
|
BR112012032126A2
(en)
|
2010-06-16 |
2017-10-17 |
Futuragene Israel Ltd Empresa Isralense |
isolated polynucleotide, nucleic acid structure, nucleic acid structure system, isolated polypeptide, plant, insecticidal composition, and method for controlling or exterminating an insect
|
ES2817780T3
(en)
|
2010-07-12 |
2021-04-08 |
The State Of Israel Ministry Of Agriculture And Rural Development Agricultural Res Organization A R |
Isolated polynucleotides and methods and plants that use them to regulate the acidity of plants
|
JP2013538555A
(en)
|
2010-07-15 |
2013-10-17 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
An isolated high affinity entity with T cell receptor-like specificity for a natural complex of MHC class II and glutamate decarboxylase (GAD) autoantigenic peptide
|
CN103108955B
(en)
|
2010-07-15 |
2015-11-25 |
工业研究与发展基金会有限公司 |
For improving the nucleic acid construct of abiotic stress tolerance in plant
|
JP2013535963A
(en)
|
2010-07-15 |
2013-09-19 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
An isolated high affinity entity with T cell receptor-like specificity for a natural complex of MHC class II and a diabetes-related autoantigenic peptide
|
US9624469B2
(en)
|
2010-07-22 |
2017-04-18 |
Cellect Biotherapeutics Ltd. |
Regulatory immune cells with enhanced targeted cell death effect
|
WO2012014208A2
(en)
|
2010-07-27 |
2012-02-02 |
Yeda Research And Development Co. Ltd. |
Methods and systems for assessing clonality of cell cultures
|
WO2012014207A2
(en)
|
2010-07-27 |
2012-02-02 |
Technion Research & Development Foundation Ltd. |
Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
|
WO2012014205A1
(en)
|
2010-07-27 |
2012-02-02 |
Technion Research & Development Foundation Ltd. |
Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
|
WO2012017439A2
(en)
|
2010-08-04 |
2012-02-09 |
Ramot At Tel-Aviv University Ltd. |
Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
|
EP2606122A1
(en)
|
2010-08-22 |
2013-06-26 |
Ramot at Tel Aviv University, Ltd. |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
WO2012025925A1
(en)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods of improving transplantation using sdf-1alpha
|
MX365161B
(en)
|
2010-08-30 |
2019-05-24 |
Evogene Ltd |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance.
|
WO2012032519A2
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing parkinson's disease
|
WO2012032520A1
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
|
WO2012032510A1
(en)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Primers for amplifying dna and methods of selecting same
|
CA2810488A1
(en)
|
2010-09-07 |
2012-03-15 |
Technion Research & Development Foundation Limited |
Novel methods and culture media for culturing pluripotent stem cells
|
CN103282047B
(en)
|
2010-09-08 |
2016-08-24 |
耶达研究及发展有限公司 |
Anti-third party's central memory T cell purposes in leukemia/lymphoma treating
|
CA2810631A1
(en)
|
2010-09-08 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
An immunosuppressive drug combination for a stable and long term engraftment
|
CN103210082A
(en)
|
2010-09-15 |
2013-07-17 |
雷蒙特亚特特拉维夫大学有限公司 |
Methods of expanding and redifferentiating islet beta cells
|
WO2012038956A1
(en)
|
2010-09-20 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating neurodegenerative diseases
|
WO2012052872A2
(en)
|
2010-10-17 |
2012-04-26 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for the treatment of insulin-associated medical conditions
|
WO2012052878A1
(en)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
|
WO2012056452A2
(en)
|
2010-10-27 |
2012-05-03 |
Nanocyte (Israel) Ltd. |
Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
|
WO2012056455A1
(en)
|
2010-10-28 |
2012-05-03 |
Yeda Research And Development Co. Ltd. |
Methods of generating antibodies to metalloenzymes
|
AR083708A1
(en)
|
2010-11-03 |
2013-03-13 |
Yissum Res Dev Co |
TRANSGENIC PLANTS WITH HIGH SACARIFICATION PERFORMANCES AND METHODS TO GENERATE THEM
|
EP2635105B1
(en)
|
2010-11-04 |
2017-12-20 |
Ben-Gurion University of The Negev Research and Development Authority |
Acyl-coa: diacylglycerol acyltransferase 1-like gene (ptdgat1) and uses thereof
|
TW201225972A
(en)
|
2010-11-15 |
2012-07-01 |
Univ Ramot |
Dipeptide analogs for treating conditions associated with amyloid fibril formation
|
EP2640404B1
(en)
|
2010-11-17 |
2017-02-22 |
Ben Gurion University of The Negev Research and Development Authority |
T-cell therapy to neurodegenerative diseases
|
US9574171B2
(en)
|
2010-12-02 |
2017-02-21 |
Technion Research & Development Foundation Ltd. |
Methods of generating corneal cells and cell populations comprising same
|
AU2011253984A1
(en)
|
2010-12-07 |
2012-06-28 |
Biobalance Llc |
Method For Identifying E. Coli M-17
|
CA2816495C
(en)
|
2010-12-15 |
2020-10-13 |
Kadimastem Ltd. |
Insulin producing cells derived from pluripotent stem cells
|
US9551006B2
(en)
|
2010-12-22 |
2017-01-24 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for improving plant properties
|
AU2011350620B2
(en)
|
2010-12-28 |
2017-03-02 |
Kamedis Ltd. |
Plant extracts for the treatment and prevention of infections
|
DK2665814T3
(en)
|
2011-01-20 |
2017-09-11 |
Protalix Ltd |
NUCLEIC ACID CONSTRUCTION FOR EXPRESSION OF ALPHA-GALACTOSIDASE IN PLANTS AND PLANT CELLS
|
US20130316358A1
(en)
|
2011-01-31 |
2013-11-28 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
US20130330349A1
(en)
|
2011-02-23 |
2013-12-12 |
Rappaport Family Institute For Research In The Medical Sciences |
High affinity molecules capable of binding a type a plexin receptor and uses of same
|
UA113843C2
(en)
|
2011-03-02 |
2017-03-27 |
|
BACTERIA TRANSGENIC PLANT CONTAINING T3SS DIFFUNCTIONAL PROTEINS
|
EP2680864B1
(en)
|
2011-03-03 |
2019-05-08 |
Ramot at Tel-Aviv University Ltd. |
Genetically modified muscle cells which express neurotrophic factors
|
ES2687771T3
(en)
|
2011-03-06 |
2018-10-29 |
Merck Serono Sa |
Cell lines with low level of fucose and its uses
|
US9061006B2
(en)
|
2011-03-08 |
2015-06-23 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for diagnosing and treating phenylketonuria (PKU)
|
WO2012123938A1
(en)
|
2011-03-17 |
2012-09-20 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Quinolone analogs for treating autoimmune diseases
|
WO2012123949A1
(en)
|
2011-03-17 |
2012-09-20 |
Ramot At Tel-Aviv University Ltd. |
Bi- and monospecific, asymmetric antibodies and methods of generating the same
|
JP6030114B2
(en)
|
2011-03-22 |
2016-11-24 |
プルリステム リミテッド |
Methods for treating radiation or chemical injury
|
KR20140036164A
(en)
|
2011-03-24 |
2014-03-25 |
뉴림 파머슈티칼스 (1991) 리미티드 |
Neuroprotective peptides
|
WO2012131680A2
(en)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating inflammation
|
WO2012137202A1
(en)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
|
ES2627154T3
(en)
|
2011-04-06 |
2017-07-26 |
Ramot At Tel-Aviv University Ltd. |
Methods of monitoring and analysis of metabolic activity profiles, diagnostic and therapeutic uses thereof
|
US9150644B2
(en)
|
2011-04-12 |
2015-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
|
CN103476924A
(en)
|
2011-04-15 |
2013-12-25 |
普拉里斯坦有限公司 |
Methods and systems for harvesting cells
|
CA3137663A1
(en)
|
2011-05-03 |
2012-11-08 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
US9192670B2
(en)
|
2011-05-04 |
2015-11-24 |
Ramot At Tel-Aviv University Ltd. |
Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
|
WO2012153333A1
(en)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Regeneration and repair of mesenchymal tissue using amelogenin
|
WO2012153336A2
(en)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Methods and device for lightening skin complexion
|
WO2012156976A1
(en)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of producing artemisinin in non-host plants and vectors for use in same
|
US20140088017A1
(en)
|
2011-05-23 |
2014-03-27 |
Yeda Research And Development Co., Ltd. |
Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
|
WO2012160526A2
(en)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations of microorganism comprising particles and uses of same
|
EP2714719B1
(en)
|
2011-05-31 |
2018-12-12 |
Hutchison Biofilm Medical Solutions Limited |
Dispersion and detachment of cell aggregates
|
WO2012164565A1
(en)
|
2011-06-01 |
2012-12-06 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for downregulating prokaryotic genes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
US9415103B2
(en)
|
2011-06-14 |
2016-08-16 |
Yeda Research And Development Co. Ltd. |
Combination therapy to prevent DCIS formation and progression to breast cancer
|
MX2014000180A
(en)
|
2011-06-23 |
2014-03-27 |
Kaiima Bio Agritech Ltd |
Common wheat, plants or parts thereof having partially or fully multiplied genome, hybrids and products thereof and methods of generating and using same.
|
CN103929950A
(en)
|
2011-07-20 |
2014-07-16 |
凯伊玛生物农业科技有限公司 |
Maize plants having a partially or fully multiplied genome and uses thereof
|
EP2550982A1
(en)
|
2011-07-27 |
2013-01-30 |
Technion Research & Development Foundation Ltd. |
Devices for surgical applications
|
EP3524679B1
(en)
|
2011-08-04 |
2021-10-06 |
Yeda Research and Development Co., Ltd. |
Micro-rna mir-19 and compositions comprising same for the treatment of medical conditions in which low adrenaline or noradrenaline level is therapeutically beneficial
|
JP6063613B2
(en)
|
2011-08-09 |
2017-01-18 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
Down-regulation of miR-7 to promote beta cell differentiation and insulin production
|
AU2012296138A1
(en)
|
2011-08-14 |
2014-03-06 |
Kaiima Bio Agritech Ltd. |
Durum wheat plants having a partially or fully multiplied genome and uses thereof
|
EP2753367A4
(en)
|
2011-09-07 |
2015-10-14 |
Yeda Res & Dev |
Olfactory signature and odorant mixture having the same
|
WO2013035071A1
(en)
|
2011-09-08 |
2013-03-14 |
Yeda Research And Development Co. Ltd. |
Novel risk biomarkers for lung cancer
|
CN103930130B
(en)
|
2011-09-08 |
2016-07-06 |
耶达研究及发展有限公司 |
Anti-third party's central type memory T cell, its production method and its application in transplanting and disease treatment
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
EP2755988B1
(en)
|
2011-09-13 |
2018-08-22 |
Monsanto Technology LLC |
Methods and compositions for weed control
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
EP3296402B1
(en)
|
2011-09-13 |
2020-04-15 |
Monsanto Technology LLC |
Methods and compositions for weed control
|
CA2848680C
(en)
|
2011-09-13 |
2020-05-19 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
EP2755466A4
(en)
|
2011-09-13 |
2015-04-15 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
WO2013054320A1
(en)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
|
EP2768851B1
(en)
|
2011-10-21 |
2017-05-31 |
Augurex Life Sciences Corporation |
Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
|
WO2013061328A2
(en)
|
2011-10-27 |
2013-05-02 |
Yeda Research And Development Co. Ltd. |
Method of treating cancer
|
WO2013067076A2
(en)
|
2011-11-03 |
2013-05-10 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for neuroprotection
|
EP2776565A1
(en)
|
2011-11-08 |
2014-09-17 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
US9736998B2
(en)
|
2011-11-23 |
2017-08-22 |
Danziger Dan Flower Farm |
Otomeria plants
|
US9617331B2
(en)
|
2011-11-27 |
2017-04-11 |
Yeda Research And Development Co. Ltd. |
Methods of regulating angiogenesis by administering agents which increase apoB-100 polypeptide
|
JP2015500279A
(en)
|
2011-12-08 |
2015-01-05 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
Mammalian fetal lung cells and therapeutic use of the cells
|
WO2013093921A1
(en)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Collagen coated synthetic polymer fibers
|
WO2013095729A1
(en)
|
2011-12-22 |
2013-06-27 |
Life Technologies Corporation |
Sequential lateral flow capillary device for analyte determination
|
CN104470542A
(en)
|
2011-12-22 |
2015-03-25 |
耶达研究及发展有限公司 |
A combination therapy for a stable and long term engraftment
|
WO2013098820A1
(en)
|
2011-12-28 |
2013-07-04 |
Kaiima Bio Agritech Ltd. |
Cultivated sorghum plant having a partially or fully multiplied genome and uses of same
|
JP2015509085A
(en)
|
2012-01-01 |
2015-03-26 |
キュービーアイ エンタープライゼズ リミテッドQbi Enterprises Ltd. |
Particles targeting ENDO180 for selective delivery of therapeutic and diagnostic agents
|
WO2013114363A2
(en)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Antimicrobial agents
|
US9603907B2
(en)
|
2012-02-01 |
2017-03-28 |
Protalix Ltd. |
Dry powder formulations of dNase I
|
WO2013118120A2
(en)
|
2012-02-06 |
2013-08-15 |
Rosetta Green Ltd. |
Isolated polynucleotides expressing or modulating micrornas or targets of same, transgenic plants comprising same and uses thereof in improving nitrogen use efficiency, abiotic stress tolerance, biomass, vigor or yield of a plant
|
SG11201404608WA
(en)
|
2012-02-13 |
2014-09-26 |
Gamida Cell Ltd |
Mesenchymal stem cells conditioned medium and methods of generating and using the same
|
KR102310704B1
(en)
|
2012-02-14 |
2021-10-08 |
옵코 바이오로직스 리미티드 |
Long-acting coagulation factors and methods of producing same
|
AU2013220005A1
(en)
|
2012-02-19 |
2014-09-04 |
Protalix Ltd. |
Oral unit dosage forms and uses of same for the treatment of Gaucher disease
|
JP6329911B2
(en)
|
2012-02-22 |
2018-05-23 |
ブレインステム バイオテック リミテッド |
MicroRNA for the production of astrocytes
|
JP2015509366A
(en)
|
2012-02-22 |
2015-03-30 |
ブレインステム バイオテック リミテッド |
Generation of neural stem cells and motor neurons
|
EP2833714A1
(en)
|
2012-03-01 |
2015-02-11 |
The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
|
EP3483184A1
(en)
|
2012-03-07 |
2019-05-15 |
Yeda Research and Development Co. Ltd |
Compositions for inhibition of quiescinsulfhydryl oxidase (qsox1) and uses of same
|
US9334308B2
(en)
|
2012-03-22 |
2016-05-10 |
Ramot At Tel-Aviv University Ltd. |
PLIF multimeric peptides and uses thereof
|
WO2013156989A1
(en)
|
2012-04-18 |
2013-10-24 |
Ramot At Tel-Aviv University Ltd. |
Lipidated glycosaminoglycan particles for the delivery of nucleic acids
|
CN104487082A
(en)
|
2012-04-19 |
2015-04-01 |
奥普科生物制品有限公司 |
Long-acting oxyntomodulin variants and methods of producing same
|
EP2841084B1
(en)
|
2012-04-24 |
2018-05-30 |
Biokine Therapeutics Ltd. |
Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer
|
EP2846819B1
(en)
|
2012-05-09 |
2017-05-03 |
Yeda Research and Development Co. Ltd. |
Variants of tace pro-domain as tnf-a inhibitor and their medical use
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
US10240161B2
(en)
|
2012-05-24 |
2019-03-26 |
A.B. Seeds Ltd. |
Compositions and methods for silencing gene expression
|
JP5868549B2
(en)
|
2012-05-24 |
2016-02-24 |
マウントゲイト グループ リミテッド |
Compositions and methods for the prevention and treatment of rabies infections
|
EP2855507B1
(en)
|
2012-06-03 |
2018-01-03 |
Ben-Gurion University of The Negev Research and Development Authority |
Functionalized titanium binding peptides and implants coated with same
|
SG10201702228QA
(en)
|
2012-06-04 |
2017-04-27 |
Opko Biolog Ltd |
Pegylated oxm variants
|
WO2014006621A1
(en)
|
2012-07-03 |
2014-01-09 |
Nanospun Technologies Ltd. |
Methods and devices for adsorption and biodegradation of petroleum
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
WO2014020599A1
(en)
|
2012-07-29 |
2014-02-06 |
Yeda Research And Development Co. Ltd. |
Use of the reductive glycine pathway for generating formatotrophic and autotrophic microorganisms
|
JP6340366B2
(en)
|
2012-07-31 |
2018-06-06 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
Methods for diagnosing and treating motor neuron disease
|
ES2813407T3
(en)
|
2012-08-06 |
2021-03-23 |
Brainstorm Cell Therapeutics Ltd |
Methods to generate mesenchymal stem cells that secrete neurotrophic factors
|
WO2014033723A1
(en)
|
2012-09-03 |
2014-03-06 |
A.B. Seeds Ltd. |
Method of improving abiotic stress tolerance of plants and plants generated thereby
|
US10543278B2
(en)
|
2012-09-12 |
2020-01-28 |
Ramot At Tel-Aviv University Ltd. |
Immunoparticles and methods of generating and using same
|
WO2014057490A1
(en)
|
2012-10-09 |
2014-04-17 |
Ramot At Tel-Aviv University Ltd. |
Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
|
CN104918639B
(en)
|
2012-10-22 |
2018-01-26 |
萨拜格Rfa公司 |
System for being delivered to therapeutic agent in living cells and nucleus
|
EP2912062A1
(en)
|
2012-10-24 |
2015-09-02 |
Yeda Research and Development Co. Ltd. |
Combinations of epidermal growth factor receptor targeting antibodies for treating cancer
|
EP2912181B1
(en)
|
2012-10-29 |
2017-11-29 |
Yeda Research and Development Co., Ltd. |
Aptamers, multimeric aptamers and uses thereof
|
BR122020018510B1
(en)
|
2012-11-20 |
2023-03-14 |
Opko Biologics Ltd |
METHOD FOR INCREMENTALLY INCREASE THE HYDRODYNAMIC SIZE OF AN ACTIVATED COAGULATION FACTOR VIIA
|
WO2015079413A2
(en)
|
2013-11-28 |
2015-06-04 |
Yeda Research And Development Co. Ltd. |
Synaptojanin-2 inhibitors and uses thereof
|
KR20150090116A
(en)
|
2012-11-29 |
2015-08-05 |
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 |
Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
MX2015008611A
(en)
|
2013-01-01 |
2016-02-03 |
Seeds Ltd Ab |
Methods of introducing dsrna to plant seeds for modulating gene expression.
|
WO2014108850A2
(en)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
High throughput transcriptome analysis
|
WO2014108854A1
(en)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Monospecific anti-hgf and anti-ang2 antibodies and bispecific anti-hgf/anti-ang2 antibodies
|
CA2894472C
(en)
|
2013-01-17 |
2021-08-17 |
Novellusdx Ltd. |
Methods and systems for identifying patient specific driver mutations
|
WO2014118785A1
(en)
|
2013-02-04 |
2014-08-07 |
Ramot At Tel-Aviv University Ltd. |
Generation of cytotoxic tumor specific cell lines and uses thereof
|
CA2902298A1
(en)
|
2013-03-06 |
2014-09-12 |
Protalix Ltd. |
Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
|
CN105121460A
(en)
|
2013-03-06 |
2015-12-02 |
波塔力克斯有限公司 |
Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy
|
EP2967082A4
(en)
|
2013-03-13 |
2016-11-02 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
BR112015023051A2
(en)
|
2013-03-13 |
2017-11-14 |
Monsanto Technology Llc |
weed control method, herbicidal composition, microbial expression cassette and polynucleotide production method
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
EP2976097B1
(en)
|
2013-03-21 |
2021-05-26 |
CollPlant Ltd. |
Compositions comprising collagen and prp for tissue regeneration and their production method
|
US20160082071A1
(en)
|
2013-03-24 |
2016-03-24 |
Biokine Therapeutics Ltd. |
Methods of treating myeloid leukemia
|
WO2014174511A1
(en)
|
2013-04-21 |
2014-10-30 |
Yeda Research And Development Co. Ltd. |
Agents for downregulation of the activity and/or amount of bcl-xl and/or bcl-w
|
CN105531365A
(en)
|
2013-04-23 |
2016-04-27 |
耶达研究及发展有限公司 |
Isolated naive pluripotent stem cells and methods of generating same
|
WO2014174520A1
(en)
|
2013-04-25 |
2014-10-30 |
Yeda Research And Development Co. Ltd. |
Use of inhibitory peptides for the treatment of inflammatory diseases
|
US20160115231A1
(en)
|
2013-05-21 |
2016-04-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Treatment of mast cell related pathologies
|
DK3003493T3
(en)
|
2013-05-27 |
2020-01-13 |
Rakuto Bio Tech Ltd |
ENZYMATIC SYSTEM CONTAINING COSMETIC COMPOSITIONS
|
ES2938044T3
(en)
|
2013-06-24 |
2023-04-04 |
Univ Ramot |
Omentum-based structure and delivery system
|
JP6668236B2
(en)
|
2013-07-19 |
2020-03-18 |
モンサント テクノロジー エルエルシー |
Composition for controlling LEPTINOTARSA and method therefor
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
WO2015015489A1
(en)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Antibody for treating diabetes and autoimmune diseases
|
EP3039030B1
(en)
|
2013-08-29 |
2018-09-19 |
Yeda Research and Development Co. Ltd. |
Selective inhibitors of alpha2 isoform of na,k-atpase and use for reduction of intra-ocular pressure
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants composed of cellular scaffolds and a vascular pedicle
|
WO2015033343A1
(en)
|
2013-09-03 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for expressing recombinant polypeptides
|
WO2015033344A1
(en)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
|
WO2015037009A1
(en)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Isolated proteins capable of binding plexin-a4 and methods of producing and using same
|
EP3046929B1
(en)
|
2013-09-17 |
2019-01-16 |
Yeda Research and Development Co., Ltd. |
Erk-derived peptides and uses thereof
|
ES2796853T3
(en)
|
2013-10-01 |
2020-11-30 |
Kadimastem Ltd |
Targeted differentiation of astrocytes from human pluripotent stem cells for use in drug screening and treatment of amyotrophic lateral sclerosis (ALS)
|
DK3060239T3
(en)
|
2013-10-21 |
2020-08-03 |
Opko Biologics Ltd |
LONG-TERM POLICPTIDES AND METHODS OF MANUFACTURE AND SUBMISSION
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10767156B2
(en)
|
2013-10-24 |
2020-09-08 |
Yeda Research And Development Co., Ltd. |
Polynucleotides encoding BREX system polypeptides and methods of using same
|
CA2928315C
(en)
|
2013-10-31 |
2023-03-21 |
Biokine Therapeutics Ltd. |
Methods of treating acute myeloid leukemia with a flt3 mutation
|
MX2016005778A
(en)
|
2013-11-04 |
2016-12-20 |
Monsanto Technology Llc |
Compositions and methods for controlling arthropod parasite and pest infestations.
|
ES2754207T3
(en)
|
2013-11-28 |
2020-04-16 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
RNA polymerase I inhibitors and uses thereof
|
ES2697757T3
(en)
|
2013-12-10 |
2019-01-28 |
Yeda Res & Dev |
Use of enzymes that catalyze the synthesis of pyruvate from formate and acetyl-CoA and bacteria that express the same
|
UA119253C2
(en)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Compositions and methods for virus control in varroa mite and bees
|
AR099092A1
(en)
|
2014-01-15 |
2016-06-29 |
Monsanto Technology Llc |
METHODS AND COMPOSITIONS FOR WEED CONTROL USING EPSPS POLYUCLEOTIDES
|
WO2015114633A1
(en)
|
2014-01-30 |
2015-08-06 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Actin binding peptides and compositions comprising same for inhibiting angiogenes is and treating medical conditions associated with same
|
JP2017506259A
(en)
|
2014-02-03 |
2017-03-02 |
イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッドYissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Use of casein kinase I inhibitors to deplete stem cells
|
JP2017506228A
(en)
|
2014-02-05 |
2017-03-02 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
MicroRNA for the treatment and diagnosis of serotonin releasing hormone, adrenergic releasing hormone, noradrenaline releasing hormone, glutamate releasing hormone and corticotropin releasing hormone related medical conditions and compositions comprising said microRNA
|
WO2015118538A1
(en)
|
2014-02-06 |
2015-08-13 |
Yeda Research And Development Co. Ltd. |
Anti cd84 antibodies, compositions comprising same and uses thereof
|
WO2015118547A1
(en)
|
2014-02-10 |
2015-08-13 |
Protalix Ltd. |
Method of maintaining disease stability in a subject having gaucher's disease
|
JP6628253B2
(en)
|
2014-02-11 |
2020-01-08 |
ブレインストーム セル セラペウティクス リミテッド |
Method for determining cell suitability
|
US20170067894A1
(en)
|
2014-03-03 |
2017-03-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method and device for detection of pseudomonas aeruginosa
|
EP2923709A1
(en)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Multi-component-multistage malaria vaccine
|
EP3125676A4
(en)
|
2014-04-01 |
2018-02-14 |
Monsanto Technology LLC |
Compositions and methods for controlling insect pests
|
WO2015155777A1
(en)
|
2014-04-10 |
2015-10-15 |
Bonus Therapeutics Ltd. |
Bone repair compositions
|
PT4026917T
(en)
|
2014-04-14 |
2024-02-12 |
Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd |
A method and kit for determining the death of cells or tissue or the tissue or cell origin of dna by dna methylation analysis
|
ES2764504T3
(en)
|
2014-04-17 |
2020-06-03 |
Yeda Res & Dev |
Methods and equipment to analyze DNA-binding residues attached to DNA
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
MX366359B
(en)
|
2014-04-27 |
2019-07-05 |
Ccam Biotherapeutics Ltd |
Humanized antibodies against ceacam1.
|
EP3058085B1
(en)
|
2014-04-28 |
2021-02-17 |
Yeda Research and Development Co., Ltd. |
Microbiome response to agents
|
AU2015257287A1
(en)
|
2014-05-04 |
2016-11-10 |
Forrest Innovations Ltd. |
Compositions and methods for reducing pathogen-induced citrus greening
|
US10294482B2
(en)
|
2014-05-22 |
2019-05-21 |
Yeda Research And Development Co. Ltd. |
Recombinant microorganisms capable of carbon fixation
|
WO2015186128A1
(en)
|
2014-06-02 |
2015-12-10 |
Kadimastem Ltd. |
Methods of inducing myelination and maturation of oligodendrocytes
|
US20170253881A1
(en)
|
2014-06-02 |
2017-09-07 |
Technion Research & Development Foundation Limited |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
CA2953347A1
(en)
|
2014-06-23 |
2015-12-30 |
Monsanto Technology Llc |
Compositions and methods for regulating gene expression via rna interference
|
EP3145951A1
(en)
|
2014-06-24 |
2017-03-29 |
InSight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
ES2791199T3
(en)
|
2014-06-25 |
2020-11-03 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Identification of cancer stem cell markers and their use for diagnosis and treatment
|
US11807857B2
(en)
|
2014-06-25 |
2023-11-07 |
Monsanto Technology Llc |
Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
|
EP3160448A4
(en)
|
2014-06-26 |
2018-11-14 |
Ramot at Tel-Aviv University Ltd. |
Liposomal formulations for delivery of nucleic acids
|
WO2016005985A2
(en)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reprogramming cells
|
JP6671363B2
(en)
|
2014-07-15 |
2020-03-25 |
イッサム リサーチ ディヴェロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミティッド |
Isolated polypeptide of CD44 and uses thereof
|
EP3172562B1
(en)
|
2014-07-21 |
2019-03-13 |
Novellusdx Ltd. |
Methods and systems for determining oncogenic index of patient specific mutations
|
JP6700249B2
(en)
|
2014-07-21 |
2020-06-10 |
ノベルラスディクス リミテッド |
Methods for measuring drug response of patient-specific mutations
|
CN114009454A
(en)
|
2014-07-29 |
2022-02-08 |
孟山都技术公司 |
Compositions and methods for controlling insect pests
|
EP3194572B1
(en)
|
2014-07-30 |
2023-10-25 |
Yeda Research and Development Co. Ltd. |
Media for culturing pluripotent stem cells
|
US10303846B2
(en)
|
2014-08-14 |
2019-05-28 |
Memed Diagnostics Ltd. |
Computational analysis of biological data using manifold and a hyperplane
|
WO2016030899A1
(en)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral scleroses
|
EP2992895A1
(en)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Three-component-multistage malaria vaccine
|
US10526416B2
(en)
|
2014-09-08 |
2020-01-07 |
Yeda Research And Development Co. Ltd. |
Anti-HER3 antibodies and uses of same
|
WO2016038610A1
(en)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (tki)
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
Nmda receptor antagonists for treating gaucher disease
|
WO2016042561A2
(en)
|
2014-09-21 |
2016-03-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Downregulating mir-132 for the treatment of lipid related disorders
|
GB2536745B
(en)
|
2014-10-20 |
2019-06-26 |
Gen Probe Inc |
Red Blood cell lysis solution
|
CN107406825B
(en)
|
2014-11-13 |
2022-04-08 |
恩祖迪克控股有限公司 |
Functional sex reversal in females of the decapod crustacean order
|
US20180042994A1
(en)
|
2014-11-17 |
2018-02-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating diseases related to mitochondrial function
|
CN107429291A
(en)
|
2014-11-17 |
2017-12-01 |
耶达研究及发展有限公司 |
The method for analyzing microorganism group
|
EP3221455B1
(en)
|
2014-11-20 |
2020-08-12 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
|
CN107208070B
(en)
|
2014-11-26 |
2021-09-07 |
技术创新动力基金(以色列)有限合伙公司 |
Targeted elimination of bacterial genes
|
KR20170081268A
(en)
|
2014-11-27 |
2017-07-11 |
단지거 이노베이션즈 엘티디. |
Nucleic acid constructs for genome editing
|
WO2016092555A2
(en)
|
2014-12-11 |
2016-06-16 |
Yeda Research And Development Co. Ltd. |
Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
WO2016103269A1
(en)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations of neural progenitor cells and methods of producing and using same
|
CN114469998A
(en)
|
2014-12-30 |
2022-05-13 |
细胞治疗神经科学有限公司 |
Methods of treating retinal diseases
|
JP6882981B2
(en)
|
2014-12-30 |
2021-06-02 |
セル キュア ニューロサイエンシズ リミテッド |
RPE cell population and how to make it
|
WO2016108240A1
(en)
|
2014-12-30 |
2016-07-07 |
Cell Cure Neurosciences Ltd. |
Assessing retinal pigment epithelial cell populations
|
US11225648B2
(en)
|
2015-01-04 |
2022-01-18 |
Protalix Ltd. |
Modified DNase and uses thereof
|
WO2016116935A1
(en)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Use of rasa2 as a prognostic and therapeutic marker for melanoma
|
CN108064288B
(en)
|
2015-01-22 |
2021-11-26 |
孟山都技术公司 |
Compositions and methods for controlling phyllometaca
|
US20180345047A1
(en)
|
2015-02-26 |
2018-12-06 |
Yeda Research And Development Co. Ltd. |
Method of promoting hair growth
|
EP3268475B1
(en)
|
2015-03-11 |
2020-10-21 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Decoy oligonucleotides for the treatment of diseases
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Anti amphiregulin antibodies, compositions comprising same and uses thereof
|
JP2018518152A
(en)
|
2015-03-27 |
2018-07-12 |
ユニバーシティ オブ サザン カリフォルニア |
CAR T cell therapy directed to LHR for treating solid tumors
|
US20180064748A1
(en)
|
2015-03-27 |
2018-03-08 |
Yeda Research And Development Co. Ltd. |
Methods of treating motor neuron diseases
|
RU2017135552A
(en)
|
2015-03-31 |
2019-04-30 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
GLUTAMATE TRANSMINASE OXALOACETATE 1 (GOT1), PREPARATIONS AND METHODS FOR THEIR RECEPTION AND APPLICATION
|
WO2016157192A1
(en)
|
2015-04-01 |
2016-10-06 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Erodium crassifolium l'her plant extracts and uses thereof
|
EP3280401B1
(en)
|
2015-04-07 |
2021-08-25 |
ELA Pharma Ltd |
Compositions for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto
|
EP3081575A1
(en)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anti-plasmodium parasite antibodies
|
EP3288547B1
(en)
|
2015-04-27 |
2023-06-07 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Egr1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
|
AU2016255724B2
(en)
|
2015-04-29 |
2020-05-14 |
The State of Israel, Ministry of Agriculture and Rural Development Agricultural Research Organization (ARO) (Volcani Center) |
Anti-phytopathogenic compositions
|
WO2016174652A1
(en)
|
2015-04-30 |
2016-11-03 |
Technion Research & Development Foundation Limited |
Chimeric antigen receptors and methods of their use
|
CN108026566A
(en)
|
2015-05-04 |
2018-05-11 |
特拉维夫大学拉莫特有限公司 |
For making the method and kit of DNA fragmentation
|
US20180161300A1
(en)
|
2015-05-11 |
2018-06-14 |
Yeda Research And Development Co., Ltd. |
Citrin inhibitors for the treatment of cancer
|
EP3298141A4
(en)
|
2015-05-17 |
2019-01-09 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Compositions and methods for treating cancer
|
WO2016185457A1
(en)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Methods of promoting lymphangiogenesis
|
WO2016185481A2
(en)
|
2015-05-20 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Method of targeting senescent cells
|
EA201792547A1
(en)
|
2015-05-21 |
2018-04-30 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
BACTERIA POPULATIONS FOR STIMULATING HEALTH CONDITION
|
AU2016273045B2
(en)
|
2015-05-29 |
2020-11-26 |
Opko Biologics Ltd. |
Pegylated oxyntomodulin variants
|
EP3302053B1
(en)
|
2015-06-02 |
2021-03-17 |
Monsanto Technology LLC |
Compositions and methods for delivery of a polynucleotide into a plant
|
US10655136B2
(en)
|
2015-06-03 |
2020-05-19 |
Monsanto Technology Llc |
Methods and compositions for introducing nucleic acids into plants
|
WO2016197064A1
(en)
|
2015-06-04 |
2016-12-08 |
Epstein Alan L |
Lym-1 and lym-2 targeted car cell immunotherapy
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
EP4026563A1
(en)
|
2015-06-18 |
2022-07-13 |
Yeda Research and Development Co. Ltd |
Conditioning protocols and use of same for tissue regeneration
|
WO2016203476A1
(en)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and compositions for diagnosing and treating urothelial cancer
|
WO2016203482A2
(en)
|
2015-06-19 |
2016-12-22 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
JP2018521983A
(en)
|
2015-07-16 |
2018-08-09 |
バイオカイン セラピューティックス リミテッド |
Compositions and methods for treating cancer
|
CA2991690A1
(en)
|
2015-07-16 |
2017-01-19 |
Yeda Research And Development Co. Ltd. |
Genetically modified anti-third party central memory t cells and use of same in immunotherapy
|
US10668094B2
(en)
|
2015-07-19 |
2020-06-02 |
Yeda Research And Development Co. Ltd. |
Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure
|
EP3324754B1
(en)
|
2015-07-22 |
2022-09-07 |
Phytopharma International Ltd. |
Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby
|
US11230696B2
(en)
|
2015-07-29 |
2022-01-25 |
Hadasit Medical Research Services And Development Ltd. |
Large scale production of retinal pigment epithelial cells
|
US20180221393A1
(en)
|
2015-08-03 |
2018-08-09 |
Biokine Therapeutics Ltd. |
Cxcr4 binding agents for treatment of diseases
|
WO2017021961A1
(en)
|
2015-08-04 |
2017-02-09 |
Yeda Research And Development Co. Ltd. |
Methods of screening for riboswitches and attenuators
|
EA201890442A1
(en)
|
2015-08-05 |
2018-07-31 |
Селл Кьюр Нейросайансес Лтд. |
OBTAINING PHOTORECEPTORS FOR THE TREATMENT OF RETITAL DISEASES
|
AU2016303632B2
(en)
|
2015-08-05 |
2022-09-29 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
WO2017025963A1
(en)
|
2015-08-10 |
2017-02-16 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods and pharmaceutical compositions for improving wound healing using cd24
|
US20180237790A1
(en)
|
2015-08-13 |
2018-08-23 |
Forrest Innovation Ltd. |
Formulations and compositions for delivery of nucleic acids to plant cells
|
WO2017033188A1
(en)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Algal oil and biofuel and methods of producing same
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
WO2017042814A1
(en)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Use of perforin positive immature dendritic cells in disease treatment
|
EP3365376A1
(en)
|
2015-10-25 |
2018-08-29 |
Yeda Research and Development Co., Ltd. |
Antibodies targeting quiescin sulfhydryl oxidase (qsox1) and uses of same
|
EP3368661A1
(en)
|
2015-10-26 |
2018-09-05 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
CN109310648B
(en)
|
2015-10-27 |
2022-06-03 |
杰伊制药公司 |
Compositions comprising cannabidiol and a second therapeutic agent for treating cancer
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method of inducing cardiomyocytes proliferation and treating heart diseases
|
WO2017077539A1
(en)
|
2015-11-03 |
2017-05-11 |
Ariel-University Research And Development Company Ltd. |
Compositions for regeneration and repair of neural tissue
|
WO2017081689A1
(en)
|
2015-11-11 |
2017-05-18 |
Ramot At Tel-Aviv University Ltd. |
Methods of detecting 5-hydroxymethylcytosine and diagnosing of cancer
|
EP3384286B1
(en)
|
2015-11-30 |
2023-04-19 |
Kadimastem Ltd. |
Methods for differentiating and purifying pancreatic endocrine cells
|
EP3176183A1
(en)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Compositions and methods for treating cancer not resistant to a tyrosine kinase inhibitor (tki)
|
WO2017103930A1
(en)
|
2015-12-16 |
2017-06-22 |
Ramot At Tel-Aviv University Ltd. |
Particles comprising decellularized omentum
|
WO2017115367A1
(en)
|
2015-12-28 |
2017-07-06 |
The National Institute for Biotechnology in the Negev Ltd. |
Composition and method for treating amyotrophic lateral sclerosis
|
WO2017118985A1
(en)
|
2016-01-06 |
2017-07-13 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating malignant, autoimmune and inflammatory diseases
|
US20190178888A1
(en)
|
2016-01-11 |
2019-06-13 |
Technion Research & Development Foundation Limited |
Methods of determining prognosis of sepsis and treating same
|
JP7019580B2
(en)
|
2016-01-21 |
2022-02-15 |
ザ ステイト オブ イスラエル ミニストリー オブ アグリカルチャー アンド ルーラル ディベロップメント アグリカルチュラル リサーチ オーガニゼイション (エー.アール.オー.) (ボルカニ センター) |
Parthenogenetic plants and their manufacturing methods
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
Composition comprising sp1 and carbon based nanoparticles and uses thereof
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive yarn
|
WO2017130205A1
(en)
|
2016-01-31 |
2017-08-03 |
Hadasit Medical Research Services And Development Ltd. |
Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
|
JP7072508B2
(en)
|
2016-02-04 |
2022-05-20 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッド |
Peptides and their use in the treatment of diseases, disorders or conditions associated with mutant p53
|
US20190142875A1
(en)
|
2016-02-14 |
2019-05-16 |
Yeda Research And Development Co. Ltd. |
Microbiome-based diagnosis, prediction and treatment of relapsing obesity
|
WO2017138008A2
(en)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
BR112018016757A2
(en)
|
2016-02-16 |
2020-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
non-protein phenylalanine analogs to inhibit cyanobacteria and plant growth.
|
US11053476B2
(en)
|
2016-02-23 |
2021-07-06 |
Exostem Biotec Ltd. |
Generation of cancer stem cells and use thereof
|
BR112018067522A2
(en)
|
2016-03-01 |
2019-02-05 |
Univ Of Rijeka Faculty Of Medicine |
human poliovirus receptor (pvr) specific antibodies
|
IL287757B
(en)
|
2016-03-03 |
2022-07-01 |
Memed Diagnostics Ltd |
Analyzing rna for diagnosing infection type
|
WO2017153982A1
(en)
|
2016-03-06 |
2017-09-14 |
Yeda Research And Development Co. Ltd. |
Method for modulating myelination
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods of isolating barrel-like proteases and identifying peptides processed thereby
|
US10421785B2
(en)
|
2016-04-11 |
2019-09-24 |
Bar-Ilan University |
Delta receptor agonist peptides and use thereof
|
CA3232826A1
(en)
|
2016-04-27 |
2017-11-02 |
Gen-Probe Incorporated |
Blood cell lysis reagent
|
WO2017203520A1
(en)
|
2016-05-22 |
2017-11-30 |
Yeda Research And Development Co. Ltd. |
Methods of using pulmonary cells for transplantation and induction of tolerance
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of agents for treating drug resistant tumors
|
US20190100732A1
(en)
|
2016-06-02 |
2019-04-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
US11820833B2
(en)
|
2016-06-05 |
2023-11-21 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Peptides that inhibit binding of EPCR to its ligand to treat inflammation
|
WO2017212494A1
(en)
|
2016-06-09 |
2017-12-14 |
Opko Biologics Ltd. |
Long-acting oxyntomodulin formulation and methods of producing and administering same
|
EP3472342A1
(en)
|
2016-06-19 |
2019-04-24 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Screening for chemotherapy resistance in human haploid cells
|
AU2017289879B2
(en)
|
2016-06-27 |
2023-04-20 |
Yeda Research And Development Co. Ltd. |
Veto cells generated from memory T cells
|
EP3482200B1
(en)
|
2016-07-10 |
2022-05-04 |
Memed Diagnostics Ltd. |
Protein signatures for distinguishing between bacterial and viral infections
|
CN109804245B
(en)
|
2016-07-10 |
2022-10-25 |
米密德诊断学有限公司 |
Early diagnosis of infection
|
US20200080050A1
(en)
|
2016-07-11 |
2020-03-12 |
Yaakov Nahmias |
Systems and methods for growing cells in vitro
|
KR20190038833A
(en)
|
2016-07-11 |
2019-04-09 |
보누스 테라퓨틱스 리미티드 |
Cell regeneration composition
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combination therapy to increase endogenous nitric oxide (no) synthesis
|
HUE064463T2
(en)
|
2016-07-11 |
2024-03-28 |
Opko Biologics Ltd |
Long-acting coagulation factor vii and methods of producing same
|
WO2018020489A1
(en)
|
2016-07-24 |
2018-02-01 |
Yeda Research And Development Co. Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
US10982252B2
(en)
|
2016-08-08 |
2021-04-20 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Bacterial systems for analyzing ubiquitylated polypeptides
|
WO2018029693A1
(en)
|
2016-08-10 |
2018-02-15 |
Ramot At Tel-Aviv University Ltd. |
Analysis of methylation status and copy number
|
US20190180846A1
(en)
|
2016-08-10 |
2019-06-13 |
Memed Diagnostics Ltd. |
System and method for analysis of biological data
|
CN109843305B
(en)
|
2016-08-14 |
2023-03-10 |
雷蒙特亚特特拉维夫大学有限公司 |
Mesenchymal cell-derived exosomes for treating neurological disorders
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(en)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating autoimmune diseases
|
WO2018047154A1
(en)
|
2016-09-07 |
2018-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anti-nkp46 antibodies and therapeutic use of same
|
WO2018051347A1
(en)
|
2016-09-14 |
2018-03-22 |
Yeda Research And Development Co. Ltd. |
Crisp-seq, an integrated method for massively parallel single cell rna-seq and crispr pooled screens
|
EP3519833A4
(en)
|
2016-09-29 |
2020-06-03 |
MeMed Diagnostics Ltd. |
Methods of prognosis and treatment
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the manufacture of medicament for treating cancer and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of a circadian rhythm disorder
|
US20190359956A1
(en)
|
2016-11-10 |
2019-11-28 |
Yeda Research And Development Co. Ltd. |
Phosphotriesterases for treating or preventing organophosphate exposure associated damage
|
US11542508B2
(en)
|
2016-11-28 |
2023-01-03 |
Yeda Research And Development Co. Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for expressing an expression product of interest
|
EP3548015A1
(en)
|
2016-11-30 |
2019-10-09 |
Yeda Research and Development Co. Ltd. |
Methods of treating liver toxicity and disorders
|
MX2018016003A
(en)
|
2016-12-01 |
2019-05-16 |
Univ Ramot |
Combined treatment for nerve injuries.
|
CN110392736A
(en)
|
2017-01-18 |
2019-10-29 |
耶达研究及发展有限公司 |
The veto cell of genetic modification and its purposes in immunization therapy
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Isolated cells genetically modified to express a disarm system having an anti-phage activity and methods of producing same
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods of culturing t cells and uses of same
|
EP3596469A1
(en)
|
2017-03-12 |
2020-01-22 |
Yeda Research and Development Co., Ltd. |
Methods of diagnosing and prognosing cancer
|
WO2018167780A1
(en)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Methods of prognosing and treating cancer
|
EP3595687A1
(en)
|
2017-03-16 |
2020-01-22 |
Lineage Cell Therapeutics, Inc. |
Methods for measuring therapeutic effects of retinal disease therapies
|
AU2018248137B2
(en)
|
2017-04-05 |
2024-03-07 |
Yeda Research And Development Co. Ltd. |
Ex-vivo culture system and methods of using same
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Methods of treating psychiatric stress disorders
|
CN110831966A
(en)
|
2017-05-10 |
2020-02-21 |
阿里埃勒科学创新有限公司 |
Method for purifying antibodies
|
EP3652541B1
(en)
|
2017-05-21 |
2022-12-14 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Combination of markers for diagnosing cancer
|
WO2018216011A1
(en)
|
2017-05-23 |
2018-11-29 |
Technion Research & Development Foundation Limited |
Agents which inhibit gads dimerization and methods of use thereof
|
US20200109408A1
(en)
|
2017-05-31 |
2020-04-09 |
Tropic Biosciences UK Limited |
Methods of selecting cells comprising genome editing events
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
WO2018229764A1
(en)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Treatment of advanced or progressive multiple sclerosis
|
WO2019012544A1
(en)
|
2017-07-13 |
2019-01-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Dual-probe digital droplet pcr strategy for specific detection of tissue-specific circulating dna molecules
|
WO2019012543A1
(en)
|
2017-07-13 |
2019-01-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Dna targets as tissue-specific methylation markers
|
US20200165671A1
(en)
|
2017-07-13 |
2020-05-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Detecting tissue-specific dna
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combination therapy for the treatment of cancer
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against transferrin receptor 1 (tfr1)-tropic arenaviruses
|
WO2019038771A1
(en)
|
2017-08-23 |
2019-02-28 |
Technion Research & Development Foundation Limited |
Compositions and methods for improving alcohol tolerance in yeast
|
KR102510576B1
(en)
|
2017-09-19 |
2023-03-14 |
트로픽 바이오사이언시즈 유케이 리미티드 |
Specific modification of non-coding RNA molecules in plants to silence gene expression
|
CA3082365A1
(en)
|
2017-11-09 |
2019-05-16 |
Pinteon Therapeutics Inc. |
Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with improved properties
|
EP3716756A4
(en)
|
2017-11-29 |
2021-09-15 |
Weedout Ltd. |
Compositions, kits and methods for controlling weed of the amaranthus genus
|
EP3717032B1
(en)
|
2017-11-29 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Methods of preventing or treating neurogenic shock
|
EP3716993A1
(en)
|
2017-12-03 |
2020-10-07 |
Yeda Research and Development Co. Ltd |
Treatment of an ischemic heart disease
|
WO2019116376A1
(en)
|
2017-12-17 |
2019-06-20 |
Yeda Research And Development Co. Ltd. |
Cop9 signalosome (csn) complex modulators and uses thereof
|
WO2019130313A1
(en)
|
2017-12-28 |
2019-07-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method to reproduce circadian rhythms on a microfluidic chip
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Endoplasmic reticulum targeting signal
|
WO2019155465A1
(en)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Methods of identifying and using agents for treating diseases associated with intestinal barrier dysfunction
|
EP3749689A1
(en)
|
2018-02-08 |
2020-12-16 |
Yeda Research and Development Co. Ltd |
Inhibitors of the 20s proteasome
|
US11571433B2
(en)
|
2018-02-23 |
2023-02-07 |
Carmel Haifa University Economic Corporation Ltd. |
Methods for treating memory impairment and cognitive dysfunction
|
WO2019167047A1
(en)
|
2018-02-28 |
2019-09-06 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods of diagnosing and treating bladder cancer
|
WO2019175869A1
(en)
|
2018-03-12 |
2019-09-19 |
Yeda Research And Development Co. Ltd |
Treatment of a heart disease
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
WO2019186569A1
(en)
|
2018-03-29 |
2019-10-03 |
Yeda Research And Development Co. Ltd. |
Use of electric field gradients to control gene expression
|
WO2019186558A1
(en)
|
2018-03-29 |
2019-10-03 |
Technion Research And Development Foundation Limited |
Vesicles comprising a pten inhibitor and uses of same
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neoantigens
|
WO2019220441A1
(en)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions and methods for treating cancer resistant to an anti-cancer agent
|
WO2019229745A1
(en)
|
2018-05-27 |
2019-12-05 |
Biolinerx Ltd. |
Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors
|
EP3802839A1
(en)
|
2018-06-07 |
2021-04-14 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Nucleic acid constructs and methods of using same
|
CA3102975A1
(en)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Methods of regenerating and transforming cannabis
|
US11873322B2
(en)
|
2018-06-25 |
2024-01-16 |
Yeda Research And Development Co. Ltd. |
Systems and methods for increasing efficiency of genome editing
|
WO2020008412A1
(en)
|
2018-07-04 |
2020-01-09 |
Ukko Inc. |
Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
|
EP3818529A2
(en)
|
2018-07-08 |
2021-05-12 |
Yeda Research and Development Co. Ltd |
Person-specific assessment of probiotics responsiveness
|
MX2021000264A
(en)
|
2018-07-11 |
2021-05-12 |
Immunity Pharma Ltd |
Peptide compounds and therapeutic uses of same.
|
CN112543773A
(en)
|
2018-07-11 |
2021-03-23 |
卡尔医学有限公司 |
SIRP alpha-4-1 BBL variant fusion proteins and methods of use thereof
|
KR20210042430A
(en)
|
2018-07-31 |
2021-04-19 |
콜플랜트 리미티드 |
Tobacco transformation event and detection method and use thereof
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
WO2020039440A1
(en)
|
2018-08-24 |
2020-02-27 |
Yeda Research And Development Co. Ltd. |
Methods of modulating m2 macrophage polarization and use of same in therapy
|
CN113038951B
(en)
|
2018-09-20 |
2024-04-30 |
耶达研究及发展有限公司 |
Method for treating amyotrophic lateral sclerosis
|
EP3856225A1
(en)
|
2018-09-25 |
2021-08-04 |
BioLineRx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
WO2020152686A1
(en)
|
2019-01-23 |
2020-07-30 |
Yeda Research And Development Co. Ltd. |
Culture media for pluripotent stem cells
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
Anti-matrix metalloproteinase 7 (mmp-7) inhibitory antibody and uses thereof
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
WO2020170239A1
(en)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of generating organoids for high throughput screening of drugs
|
JP2022521010A
(en)
|
2019-02-21 |
2022-04-04 |
イッスム・リサーチ・デベロプメント・カムパニー・オブ・ザ・ヘブリュー・ユニバシティー・オブ・エルサレム リミテッド |
Methods for reducing drug-induced nephrotoxicity
|
MX2021010611A
(en)
|
2019-03-05 |
2021-11-12 |
The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo |
Genome-edited birds.
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
WO2020194317A1
(en)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Method of treating lipid-related disorders
|
WO2020202142A2
(en)
|
2019-03-31 |
2020-10-08 |
Yeda Research And Development Co. Ltd. |
Anti-viral and anti-tumoral compounds
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
US20220220559A1
(en)
|
2019-05-13 |
2022-07-14 |
Yeda Research And Development Co. Ltd. |
Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutated neopeptides
|
JP2022533745A
(en)
|
2019-05-22 |
2022-07-25 |
ハダシット メディカル リサーチ サービシーズ アンド ディベロップメント リミテッド |
Method for culturing human pluripotent cells
|
CA3140406A1
(en)
|
2019-05-28 |
2020-12-03 |
Shanghaitech University |
Composition and methods to treat ectodermal dysplasia 2, clouston type
|
WO2020250232A1
(en)
|
2019-06-12 |
2020-12-17 |
Hadasit Medical Research Services And Development Ltd. |
Methods of generating oligodendrocytes
|
WO2020255124A1
(en)
|
2019-06-16 |
2020-12-24 |
Yeda Research And Development Co. Ltd. |
Method for stabilizing intracellular rna
|
US20220251193A1
(en)
|
2019-06-27 |
2022-08-11 |
Ramot At Tel-Aviv University Ltd. |
Semaphorin 3a antibodies and uses thereof
|
EP3994268A1
(en)
|
2019-07-04 |
2022-05-11 |
Ukko Inc. |
De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity
|
CA3146248A1
(en)
|
2019-07-11 |
2021-01-14 |
Kahr Medical Ltd. |
Heterodimers and methods of use thereof
|
EP3999851A4
(en)
|
2019-07-16 |
2023-04-12 |
Ramot at Tel-Aviv University Ltd. |
Compositions and methods for the treatment of tuberculosis
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
WO2021019526A1
(en)
|
2019-07-29 |
2021-02-04 |
Yeda Research And Development Co. Ltd. |
Methods of treating and diagnosing lung cancer
|
WO2021019536A1
(en)
|
2019-07-30 |
2021-02-04 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
|
EP4014046A1
(en)
|
2019-08-12 |
2022-06-22 |
Yeda Research and Development Co. Ltd |
Dna repair blood test for predicting response of lung cancer patients to immunotherapy
|
WO2021033176A1
(en)
|
2019-08-22 |
2021-02-25 |
Ariel Scientific Innovations Ltd. |
Scaled-up methods for purifying antibodies
|
EP4021463A1
(en)
|
2019-08-27 |
2022-07-06 |
Yeda Research and Development Co. Ltd |
Treatment of bacterial vaginosis
|
WO2021048852A1
(en)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Methods of treating breast cancer
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembly of protein complexes on a chip
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
US20240117386A1
(en)
|
2019-10-31 |
2024-04-11 |
Yeda Research And Development Co. Ltd. |
Engineered autotrophic bacteria for co2 conversion to organic materials
|
AU2020384953A1
(en)
|
2019-11-11 |
2022-06-23 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Insect control nanobodies and uses thereof
|
US20230022576A1
(en)
|
2019-11-19 |
2023-01-26 |
Protalix Ltd. |
Removal of constructs from transformed cells
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
Method of treating alzheimer’s disease
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
Systems and methods for identifying cells that have undergone genome editing
|
EP4077731A1
(en)
|
2019-12-22 |
2022-10-26 |
Yeda Research and Development Co. Ltd |
Diagnosis of frontotemporal dementia
|
US20230048361A1
(en)
|
2019-12-31 |
2023-02-16 |
Kahr Medical Ltd. |
Methods of culturing t cells and uses of same
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods of treating atopic dermatitis
|
WO2021137231A1
(en)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of same
|
IL272074A
(en)
|
2020-01-15 |
2021-07-29 |
Immunity Pharma Ltd |
Peptide compounds and methods of treating diseases using same
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multispecific antibodies for use in treating diseases
|
WO2021152584A1
(en)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Methods of analyzing cell membranes
|
WO2021152586A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Methods of analyzing microbiome, immunoglobulin profile and physiological state
|
WO2021152587A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Treating acute liver disease with tlr-mik inhibitors
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Articles of manufacture comprising anti pd-l1 antibodies and their use in therapy
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Methods of treating cancer
|
CA3170374A1
(en)
|
2020-02-09 |
2021-08-12 |
Nlc Pharma Ltd |
Rapid detection test for sars-cov-2
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
Method for analyzing cell clusters
|
EP4110823A1
(en)
|
2020-02-26 |
2023-01-04 |
A2 Biotherapeutics, Inc. |
Polypeptides targeting mage-a3 peptide-mhc complexes and methods of use thereof
|
US20230127559A1
(en)
|
2020-03-16 |
2023-04-27 |
Yeda Research And Development Co. Ltd. |
Peptide analogs and use of same in treating diseases, disorders or conditions associated with mutant p53 protein
|
EP4126226A1
(en)
|
2020-03-29 |
2023-02-08 |
Yeda Research and Development Co. Ltd |
Variants of beta-glucocerebrosidase for use in treating gaucher disease
|
IL296698A
(en)
|
2020-03-31 |
2022-11-01 |
Biomuse Ltd |
Bacteria for the prevention and treatment of smoke-induced lung damage
|
WO2021205444A1
(en)
|
2020-04-06 |
2021-10-14 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing cancer and predicting responsiveness to therapy
|
WO2021205459A1
(en)
|
2020-04-07 |
2021-10-14 |
Ramot At Tel-Aviv University Ltd. |
Cannabidiol-containing compositions and uses thereof
|
CA3177360A1
(en)
|
2020-04-13 |
2021-10-21 |
Exoprother Medical Ltd. |
Cell-derived vesicles comprising wild-type p53 protein for antiviral therapy
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
WO2021229577A1
(en)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagen as a delivery tool for metal-based anti-viral agents
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Indexing spatial information for a single-cell downstream applications
|
US20230293530A1
(en)
|
2020-06-24 |
2023-09-21 |
Yeda Research And Development Co. Ltd. |
Agents for sensitizing solid tumors to treatment
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
Mage-a1 specific t cell receptor and uses thereof
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
WO2022038536A1
(en)
|
2020-08-18 |
2022-02-24 |
International Rice Research Institute |
Methods of increasing outcrossing rates in gramineae
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Method for modulating weight
|
IL301503A
(en)
|
2020-09-23 |
2023-05-01 |
Yeda res & development co ltd |
Methods and compositions for treating coronaviral infections
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
Method of diagnosing breast cancer
|
US20230374447A1
(en)
|
2020-10-05 |
2023-11-23 |
Protalix Ltd. |
Dicer-like knock-out plant cells
|
IL301970A
(en)
|
2020-10-07 |
2023-06-01 |
Protalix Ltd |
Long-acting dnase
|
WO2022079719A1
(en)
|
2020-10-15 |
2022-04-21 |
Yeda Research And Development Co. Ltd. |
Method of treating myeloid malignancies
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for rna editing and methods of using same
|
KR20230107296A
(en)
|
2020-11-09 |
2023-07-14 |
1이 테라퓨틱스 엘티디. |
Methods for Treating or Preventing Bacterial Infections Based on Catalytic Sequences
|
AU2021387979A1
(en)
|
2020-11-26 |
2023-03-30 |
Ukko Inc. |
Modified high molecular weight glutenin subunit and uses thereof
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling ubiquitination of mlkl for treatment of disease
|
EP4267742A2
(en)
|
2020-12-28 |
2023-11-01 |
1E Therapeutics, Ltd. |
P21 mrna targeting dnazymes
|
AU2021411103A1
(en)
|
2020-12-28 |
2023-07-13 |
1E Therapeutics, Ltd. |
P21 mrna target areas for silencing
|
EP4274886A2
(en)
|
2021-01-10 |
2023-11-15 |
Supermeat the Essence of Meat Ltd. |
Pluripotent stem cell aggregates and microtissues obtained therefrom for the cultured meat industry
|
US20240083843A1
(en)
|
2021-01-14 |
2024-03-14 |
Yeda Research And Development Co. Ltd. |
Methods of producing vitamin d
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and combinations of same for the treatment or prevention of coronavirus infection
|
CA3208536A1
(en)
|
2021-02-18 |
2022-08-25 |
Ravid STRAUSSMAN |
Genetically modified bacteria for generating vaccines
|
WO2022175952A1
(en)
|
2021-02-18 |
2022-08-25 |
Yeda Research And Development Co. Ltd. |
Method of generating vaccines
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for ex-utero mouse embryonic development
|
JP2024514252A
(en)
|
2021-03-30 |
2024-03-29 |
バイオエムエックス・リミテッド |
PSEUDOMONAS bacteriophage and its use
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
A combined use of ketamine and retigabine (ezogabine) for the treatment of psychiatric disorders
|
WO2022238947A1
(en)
|
2021-05-12 |
2022-11-17 |
Biomx Ltd. |
Staphylococcus bacteriophage and uses thereof
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Anti-microbial peptide (amp) signatures for diagnostics, stratification, and treatment of microbiome-associated disease
|
CA3219233A1
(en)
|
2021-06-06 |
2022-12-15 |
Ravid STRAUSSMAN |
Combined treatment for cancer
|
CN117836402A
(en)
|
2021-06-13 |
2024-04-05 |
耶路撒冷希伯来大学伊森姆研究发展有限公司 |
Method for reprogramming human cells
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
WO2022264076A1
(en)
|
2021-06-16 |
2022-12-22 |
Seedx Technologies Inc. |
Methods of sorting matthiola seeds
|
KR20240031315A
(en)
|
2021-07-02 |
2024-03-07 |
트로픽 바이오사이언시즈 유케이 리미티드 |
Delaying or preventing browning of banana fruit
|
WO2023003809A1
(en)
|
2021-07-18 |
2023-01-26 |
Gamida-Cell Ltd. |
Therapeutic nk cell populations
|
WO2023002492A1
(en)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Codon optimization of nucleic acids
|
EP4130028A1
(en)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Engineered tcr complex and methods of using same
|
WO2023012584A2
(en)
|
2021-08-03 |
2023-02-09 |
Genicity Limited |
Engineered tcr complex and methods of using same
|
CA3228570A1
(en)
|
2021-08-10 |
2023-02-16 |
Yona Geffen |
Engineered nk cells, methods of their production and uses thereof
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in treating diseases
|
WO2023105526A1
(en)
|
2021-12-08 |
2023-06-15 |
Yeda Research And Development Co. Ltd. |
Multipotent lung progenitor cells for lung regeneration
|
WO2023209708A1
(en)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions for altering cyclic adp-ribose secondary messenger signalling
|